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ABSTRACT
Association of Perfluorinated Chemicals with Endocrino-Carcinogenetic, Obesogenic and
Metabolic Health and with Markers of Chronic Inflammation and Oxidative Stress
by
Ogbebor Enaholo Omoike

First, this study examined the association of perfluorinated chemicals with 1) cardio-metabolic
health outcomes and 2) the association of phthalates with cardiometabolic health outcomes, and
3) cardio-metabolic health outcomes while assessing the possibility of additive interactions
between perfluorinated chemicals (PFCs) and phthalates. Second, association with markers of
chronic inflammation and oxidative stress were explored. Finally, this study examined the
association of these chemicals with estrogenic cancers- Breast cancer, prostate cancer, uterine
cancer and ovarian cancer.

Using data from the National Health and Nutrition Examination Survey (NHANES), logistic
regression models were used to investigate the relationship between PFCs and the cardiometabolic health outcomes adjusting for covariates. An interaction term between PFCs and
phthalates was added to the main effect model to assess the possibility of effect modification.
Generalized linear models were used to examine associations between PFCs and inflammatory
and oxidative stress markers per unit increase in exposure to PFCs while adjusting for covariates.
Binomial logistic regression was used in investigating the association between quartiles of PFCs
and presence or absence of cancer while also adjusting for covariates. Discriminant analysis was
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used to assess the correlation between individual PFCs compounds and individual cancer
categories.

Perfluorononanoic acid (PFNA) was associated with increased odds of central obesity in
females, odds ratio (OR): 1.10; 95% confidence interval (CI): (1.01, 1.21). Perfluorohexane
sulfonic acid (PFHS), Perfluorononanoic acid (PFNA), Perfluorooctanoic acid (PFOA),
Perfluorooctane sulfonic acid (PFOS), and Perfluorodecanoic acid (PFDE) were all significantly
associated with lymphocyte counts. Beta (95% CI); 0.03(0.02,0.05), 0.04(0.02,0.05), 0.05(0.03,
0.07), 0.04(0.03,0.05), 0.03(0.01,0.04) and with serum iron 0.07(0.05,0.09), 0.04(0.02,0.07),
0.10(0.07,0.12), 0.05(0.03,0.07), 0.04(0.02,0.06) and serum albumin 0.02(0.02,0.02),
0.02(0.02,0.03), 0.03(0.03,0.04), 0.02(0.02, 0.023), 0.01 (0.01, 0.05). Only PFHS, PFNA, PFOA
and PFOS were associated with serum total bilirubin 0.04(0.03,0.05), 0.02(0.00,0.03),
0.06(0.04,0.08), 0.03(0.02,0.05). PFCs studied were associated with increased odds of breast,
prostate, uterine and ovarian cancers, p<0.05. Using discriminant analysis, PFOA was more
correlated with breast cancer (0.7), PFOS was more correlated with prostatic cancer (0.76),
PFHS was more correlated with uterine cancer (0.7) and PFHS was more correlated with ovarian
cancer (0.85).
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Chapter 1. Introduction
Environmental exposures have been linked with a constellation of public health issues
with population growth, economic development and technology acting as the driving force. This
leads to increased production, consumption and emissions or waste release of these
environmental hazards with resultant pollution. Pollution leads to increased external exposure,
increased absorbed dose and increased target organ dose. The resultant effect of the increased
exposure of these toxic substances above safe threshold levels is the morbidity and mortality of
persons. In an ideal setting, action plans aimed at abating the increased exposure are usually
aimed at using economic and social policies to promote clean technology and controlling
emissions of these chemicals by setting threshold limits on production which leads to
environmental improvements. Steps are also taking at raising awareness to these chemicals
through information dissemination mediums and treating morbidity as they arise to prevent
mortality (“The DPSEEA framework | Integrated Environmental Health Impact Assessment
System,” sourced from http://www.integratedassessment.eu/eu/guidebook/dpseea_framework.html on 12.7.2019.).
To design an action plan, the basic principles of the PRECEDE-PROCEED model by
Glanz et al. are followed. These include a social assessment, an epidemiological assessment, a
behavioral assessment and as relevant to this dissertation, an environmental assessment. In these
initial steps, public health practitioners learn about the needs of the population being studied
through a form of “educational diagnosis” and, through testing, are able to observe the increased
exposures to perfluorinated chemicals and the attendant increased disease and mortality as a
result of these exposures where they exist. The next step is to ‘proceed’ through an “ecological
perspective” by implementing interventions aimed at reducing the exposures to these chemicals
11

which include use of clean technology, emission control and process/product control. These
control interventions are subsequently evaluated against a backdrop of formative data to
ascertain their benefits and effectiveness. Should they be effective, they result in environmental
improvements aimed at combating (PFCs) pollution. Subsequent exposures are reduced
drastically by creating awareness and educating the public. Treatment is reserved for disease
morbidity aimed at preventing mortality (Glanz & Rimer, 2005).
Endocrine disrupting chemicals are a heterogeneous group of chemicals that interfere
with the internal milleu and hormones of humans perturbing the normal homeostatic balance
(Papalou, Kandaraki, Papadakis, & Diamanti-Kandarakis, 2019). They affect multiple organ
systems by a coordinated attack on various metabolic pathways associated with various organs in
the body including the hypothalamus, adipose tissue, skeletal muscle, pancreatic beta cells and
the liver (Papalou et al., 2019). They can permanently alter the genome and affect subsequent
generations through their epigenetic effects occurring during crucial phases of the growth and
development of fetuses and the end result includes metabolic diseases manifesting as obesity,
diabetes mellitus, metabolic syndrome, non-alcoholic fatty liver disease and cancers Papalou et
al., 2019; Wan et al., 2013.
Perfluorinated chemicals, PFCs (and phthalates) are known endocrine disrupting
chemicals with the former been less investigated thus far compared to the latter. The exposure
pathway for perfluorinated chemicals can be better understood using the DPSEEA model in
figure 1.1 adapted from the Integrated Environmental Health Impact Assessment System and the
WHO MEME models. DPSEEA stands for driving force, pressure, state, exposure, effect and
action (“The DPSEEA framework | Integrated Environmental Health Impact Assessment
System,” sourced from http://www.integrated12

assessment.eu/eu/guidebook/dpseea_framework.html on 12.7.2019., (“WHO | Concept of
children’s environmental health indicators,” 2016).
Using this model, the driving force behind the use of PFCs has been economic
development and population growth. Consumer product demands exerts pressure on the
continuous production, consumption and waste release/emission of these persistent
environmental chemicals. This leads to PFCs polluting the environment and with their resistance
to biodegradation and photolysis, remain in the environment for decades. Exposure occurs when
these chemicals are ingested, inhaled or absorbed through dermal contact leading to an absorbed
dose which reaches target organs and potentially causes the endocrino-carcinogenic health
effects, metabolic effects, effects on inflammatory markers along with other health effects.
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Figure 1.1 DPSEEA and Preceed-Proceed Model. Adapted from the WHO MEME Model
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Significance
Research gaps on the health effects of perfluoroalkyl compound exposure: PFCs are
perfluorinated aliphatic carboxylic and sulphonic acids and some polyfluoroalkyl substances that
degrade into perfluoroalkyl substances. They are man-made fluorocarbons with an additional
functional group which could be carboxylates, sulphonates or phosphonates (Liu, Wen, Chu, &
Lin, 2018). Perfluoroalkyl substances are widely used due to their ability to act as good
surfactants (Agency for Toxic Substances and Disease Registry (ATSDR), 2018). Due to their
surfactant characteristics, they are popular as surface protectants for paper and cardboards
products, in carpeting, fire-fighting foams and non-stick coatings on cookware with their ability
to act as repellants for water, soil and grease on the latter. Their use has public health
implications due to their environmental persistence and the myriad of health effects they have
been linked to. Perfluorooctane sulfonic acid production has been banned in the United States
(U.S.) but its environmental persistence remains a public health threat. Perfluoroalkyl
compounds that have been detected in the serum of U.S. residents by way of measurement
include perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorohexane
sulfonic acid (PFHS), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDE),
perfluoroundecanoic acid (PFUA), perfluoroheptanoic acid (PFHpA), perfluorobutane sulfonic
acid (PFBuS), perfluorobutyric acid (PFBA), perfluorododecanoic acid (PFDoA),
perfluorohexanoic acid (PFHxA), perfluorooctane sulfonamide (PFOSA), 2-(N-Methylperfluorooctane sulfonamide) acetic acid (Me-PFOSA-AcOH), 2-(N-Ethyl-perfluorooctane
sulfonamide) acetic acid (Et-PFOSA-AcOH) (ATSDR, 2018). PFOA, PFOS, PFHS, PFNA, and
PFDE were the compounds concentrated on in this study because these were the compounds
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detected in soil, water, and air (Agency for Toxic Substances and Disease Registry (ATSDR),
2018) and in greater than 94% of the study participants.
Over the last 50 years the global prevalence of obesity, diabetes, and metabolic syndrome
have increased exponentially (Ogden, Carroll, Kit, & Flegal, 2014) with individuals weighing
more than they did 20 to 30 years ago when given the same caloric intake and performing the
same physical activity (Papalou et al., 2019). Perfluoroalkyl chemicals and phthalate exposure
have been linked individually with increased odds of central obesity, metabolic syndrome, lipid
profiles and insulin resistance by various studies (James-Todd, Huang, Seely, & Saxena,
2016)(Ko et al., 2019)(Liu et al., 2018), though limited studies presently have thoroughly
examined the possible interactive or moderative effect of phthalate exposures on concurrent
PFCs exposures given these health outcomes. With the fact that individuals could be exposed to
both chemicals concurrently and with documented possible interaction of these endocrine
disrupting chemicals (Papalou et al., 2019), this knowledge gap requires further exploration.
Environmental exposures are widely linked to various forms of neoplasms due to their
endocrine disrupting properties and epigenetic mechanisms. Environmental chemicals such as
Bisphenol S, which have epigenetic and endocrine disrupting properties, just like perfluorinated
chemicals, have been linked with the progression of breast cancer cells (Huang et al., 2019).
Perfluorinated chemicals have also been identified as potential risk factors in the development of
breast cancer (Bonefeld-Jorgensen et al., 2011), but little is known about the association of these
chemicals with carcinogenesis associated with altering the estrogenic milleu in humans and the
potential cancers that could arise thereof. Also, there are gaps pertaining to the concentration or
concentration range, if any, that are associated with carcinogenesis especially when comparing
high concentration of exposure to low concentrations of exposure.
16

Thus far in the literature, health effects of perfluorinated chemicals have been linked to
different pathologic and physiologic mechanisms including increased gene expression of
peroxisome proliferator activated receptor gamma (PPARγ) and enhancing of cytosine-cytosineadenosine-adenosine-thymidine (CCAAT) motifs present in several gene promoters (Ma et al.,
2018). There however is limited knowledge on the effects of perfluorinated chemicals on
inflammatory and oxidative stress markers which have been found to be central to the
pathological basis of most disease processes (Goljan, 2014) at a time when other environmental
exposures have been strongly linked to inflammatory and oxidative stress markers (Yuan,
Meeker, & Ferguson, 2017).
With the knowledge gaps stated above, there are pertinent contributions this study can
make to the existing literature by addressing the specific aims itemized below using
epidemiological tools. This study seeks to investigate the associations between PFCs and cardiometabolic conditions and between phthalates and cardiometabolic conditions. We also sought for
possible interactive associations between perfluorinated chemicals and phthalates on obesity and
other metabolic derangements and examine the potential associations between the exposure to
perfluorinated chemicals and the development of chronic inflammation and oxidative stress
using biomarkers. This was done to show a possible mechanism in the disease development
process. Lastly, the potential association between these PFCs exposures as known endocrine
disruptors and the development of estrogenic carcinogenesis which typically involve the breast,
prostate, ovaries, and uterus was explored. Due to the persistent and chronic nature of
perfluorinated chemical exposure, emphasis was laid on the markers of inflammation that are
chronic in nature. This dissertation aimed at examining the association between perfluoroalkyl
chemicals and chronic health conditions and assessing their relationship with markers of
17

inflammation and oxidative stress as part of the underlying pathologic mechanisms of disease
formation.
Specific Aims
1. Examine the associations between perfluoroalkyl chemicals and general- and central- obesity,
as well as other cardio-metabolic conditions and effect modification by phthalates
a. Examine the association between perfluoroalkyl chemicals and general- and central
obesity and effect modification by phthalates.
b. Examine the association between perfluoroalkyl chemicals and other cardiometabolic conditions/risk factors (hypercholesterolemia, systolic hypertension,
diastolic hypertension, hyperglycemia, hypertriglyceridemia) and effect modification
by phthalates
2. Assess the association between perfluoroalkyl chemicals and markers of systemic and endorgan chronic inflammation and oxidative stress.
3. Examine the association between perfluoroalkyl chemicals and estrogenic cancers by exposure
concentration.
Based on the existing literature, the hypothesis stipulated is- PFCs are positively associated with
general and central obesity, hypercholesterolemia, systolic hypertension, diastolic hypertension,
hyperglycemia and hypertriglyceridemia and this association is moderated additively by
phthalate exposure; Inflammation and oxidative stress are positively associated with the disease
mechanisms associated with perfluoroalkyl chemicals and thirdly, PFCs compounds are
associated with increased odds of one or more estrogenic cancers due to their endocrine
disrupting properties with the odds of cancer increasing with exposure concentration.
18

Literature Review
PFCs have been detected in all media including air, water (surface and ground), soil and
food. They are stable in the environment and resistant to degradation due to their chemical
structure which also results in their environmental persistence. PFCs are also capable of being
transported over very long distances exemplified by their presence in the Arctic region and in
oceans (Agency for Toxic Substances and Disease Registry (ATSDR), 2018). Predominant
forms of exposure to PFCs come from ingestion through food and water, inhalation from dust
(atmospheric) and dermal contact. Persons living around chemical facilities and around military
bases or around commercial airports where they are used in military drills and other places where
fires have occurred are thought to have higher exposure levels. However, since production has
been stopped for a few of the compounds of PFCs in the United States (U.S.), exposure levels
may be lower currently but these compounds still pose a significant public health problem due to
their environmental persistence and persistence in the human biological system (Yu, Riker, Lu,
& Fan, 2019). PFC compounds are not metabolized in humans and animals hence they lack
biomarkers of exposure (ATSDR, 2018). Health adverse effects associated with PFCs include
liver damage, decreases in fetal weight, increased serum lipids, thyroid disease, decreased
antibody responses, decreased fertility and pre-eclampsia (ATSDR, 2018).
Phthalates are diesters of phthalic acid. They are man-made chemicals synthesized from
alcohol and phthalic anhydrides and could be of high molecular weight or low molecular weight.
The high molecular weight phthalates like di(2-ethylhexyl) phthalates [DEHP], di-n-octyl
phthalate, [DnOP], di-isononyl phthalate [DiNP] are used to make plastics flexible for use in
medical devices, coverings for walls and floors and for food ware. Low molecular weight
phthalates are used for personal care products (cologne, lotions, and cosmetics), solvents and
19

plasticizers for varnishes, coatings, lacquers and for medications which have timed releases and
include diethyl phthalate [DEP] and dibutyl phthalate [DBP] (Hauser & Calafat, 2005). Most of
the U.S. population including children could be exposed to phthalates (Muñoz et al., 2018).
Persons could be exposed to phthalates through inhalation and ingestion (mainly) and dermal
contact. Phthalates have short half-lives in the human biological system, they are rapidly
metabolized and excreted in the urine and feces and do not accumulate, making the urine an
important source of phthalate biomarkers (Hauser & Calafat, 2005). Human studies have
pointed to potential association between phthalate exposure and altered semen quality, premature
mammary gland development in females, shortened pregnancies and decreased anogenital
distances in male infants (Hauser & Calafat, 2005).
The prevalence of obesity and metabolic syndrome has steadily increased over the years
with prevalence rates of obesity ranging from 17 percent to 42 percent and metabolic syndrome
ranging from 12 percent to 47 percent depending on the age group and region of the U.S. (Gurka,
Filipp, & DeBoer, 2018). There is now mounting evidence that the observed spike in metabolic
diseases cannot be attributed only to increased caloric intake, physical inactivity, sleep deficit
nor ageing alone (Papalou et al., 2019). Endocrine disrupting chemicals such as PFCs have been
linked with the development of obesity through the disruption of hormonal actions and
epigenetic mechanisms (Cock et al., 2016). Specifically, PFOA exposure has been associated
with adipocyte proliferation and differentiation as well as an increase in the accumulation of
lipids and triglycerides. Probable mechanisms include increased gene expression of peroxisome
proliferator activated receptor gamma (PPARγ), CCAAT/enhancer, binding proteins α, fatty acid
binding protein 2, and lipoprotein lipase (Ma et al., 2018). These result in the development of
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increased percentage body fat in some instances and metabolic syndrome, overweight and
obesity (Hartman et al., 2017; Lauritzen et al., 2018; Yang et al., 2018).
In occupationally exposed workers, PFOA exposure was observed to have no clinically
significant hepatic toxicity but was hypothesized to modulate hepatic responses to obesity and
xenobiotics (Gilliland & Mandel, 1996). Perfluoroalkyl substance (PFOA and PFOS) exposure
has also been positively associated with total cholesterol in a middle-aged Danish population and
lipid levels in children in the U.S. (Eriksen et al., 2013; Geiger et al., 2014). Alterations in body
total cholesterol and lipids in general have been linked to cardiovascular diseases including
abnormal blood pressure (Graham et al., 2012). Central obesity has a stronger correlation with
cardiovascular disease compared to general obesity, this is particularly important because PFCs
exposure has been linked with central obesity as previously noted. Other pertinent manifestations
of PFCs exposure include adult onset poor glycemic control which is associated with type II
diabetes mellitus (Sahakyan et al., 2015; Al-Khawaldeh et al., 2012).
Inflammation can either be acute or chronic. Acute inflammation is defined as a transient
and early response to injury involving the release of chemical mediators resulting in
characteristic small vessel and leukocyte (primarily neutrophil) responses. Chronic inflammation
is defined as prolonged inflammation lasting weeks to years that most often results from
persistence of an injury (exposure) causing agent. The primary cells responsible are monocytes
and macrophages along with lymphocytes, plasma cells and eosinophils. Oxidative stress is a
condition which results in damage to macromolecules (e.g., proteins and deoxyribonucleic acid)
due to reactive oxygen species as a result of inefficiency of cellular anti-oxidant systems (Goljan,
2014). Inflammation and oxidative stress give an insight into the pathological basis of a good
number of disease processes.
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Inflammation has a crucial role to play in a variety of diseases such as atherosclerosis
(Rafieian-Kopaei, Setorki, Doudi, Baradaran, & Nasri, 2014), heart failure (Glezeva et al.,
2015b), hemolysis in sickle cell disease patients (Wongtong, Jones, Deng, Cai, & Ataga, 2015b),
poor prognosis in patients with cancers (Hu et al., 2014b), coronary artery disease (Shantsila et
al., 2014b) with alveolar macrophages (monocytes) in particular representing a unique leukocyte
population that has been shown to respond to airborne irritants and microbes (Vlahos &
Bozinovski, 2014). Environmental exposures have been found to have an association with
markers of inflammation and oxidative stress in humans as well (Ferguson, Loch-Caruso, &
Meeker, 2011).
PFOA have been linked with a number of cancers in animal species involving liver,
pancreatic tissue and Leydig cells due to possible activation of peroxisome proliferator activated
receptor alpha, PPARα, but little specifics are known about their association and effect on
humans (Agency for Toxic Substances and Disease Registry (ATSDR), 2018). In a study done
on prostatic tissues, exposure to phtahlate esters were responsible for proliferation of prostatic
cancer cells (Zhu et al., 2019), while other studies showed positive associations with breast
cancer risk in alkyl phenolic compounds but no effect on prostatic cancer risk (PeremiquelTrillas et al., 2019). Other hosts of disease or pathological abnormalities have been linked with
exposures to environmental contaminants including a decrease in reproductive hormones with
pesticides (Omoike, Lewis, & Meeker, 2015), polycystic ovarian syndrome and metabolic
syndrome with bisphenol A (Hong et al., 2017); (Y. Hu et al., 2018) as well as cerebrovascular
accidents (Lim, Lee, Lee, & Jee, 2018).
With the endocrine disrupting properties linked to PFCs, and their activation and
modification of genetic properties, there is need for exploration of other possible health effects.
22

Similarly, while some other environmental exposures have been documented to have
associations with markers of inflammation and oxidative stress, little is known about the
systemic effects of PFcs on these markers.
Chapter Organization
Chapter 2: Associations between perfluorinated chemical exposures, obesity and other
cardio-metabolic conditions: findings from NHANES 2007-2012
Chapter 3: Association between perfluorinated chemical exposures and markers of
inflammation and oxidative stress
Chapter 4: Associations between perfluorinated chemical exposure and estrogenic
cancers
Chapter 5: Discussion and Conclusion
Public Health Significance
Our findings will enable government agencies like the Environmental Protection
Agencies (EPA), Occupational Safety and Health Administration (OSHA), and the Food and
Drug Administration (FDA) by way of regulations, set minimum thresholds for exposure to these
substances in the workplace- through 8 hour maximum exposure limits and outside of the
workplace- through 24 daily exposure limits. Other governmental agencies like the Agency for
Toxic Substance and Disease Registry (ATSDR) and the National Institute of Occupational
Safety and Health (NIOSH) can put forward recommendations. Also, regulations and
recommendations will also be put forward or where they already exist, adjusted, concerning
PFCs maximum allowable concentrations in food and water.
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Data Sources
Data from the National Health and Nutrition Examination Survey (NHANES) was
utilized for this project. This section describes each of the data sources and limitations.
NHANES is a comprehensive survey program that was designed by the National Center
for Health Statistics (NCHS) of the Center for Disease Control and Prevention (CDC) to study
the health and nutritional status of children and adults by interviewing and taking laboratory and
physical measurements (“NHANES-About the National Health and Nutrition Examination
Survey, sourced from https://www.cdc.gov/nchs/nhanes/about_nhanes.htm on 10.28.2019” ). It
commenced in the 1960s and became continuous in 1999 examining 5000 persons each year.
Survey collects data on estimated and reported chronic disease condition prevalence and
examines risk factors of certain diseases, as well as health related practices.
Samples are representative of the entire US population with over-sampling of African
Americans, Hispanics and person over 60 years of age (“NHANES - About the National Health
and Nutrition Examination Survey, sourced from
https://www.cdc.gov/nchs/nhanes/about_nhanes.htm on 10.28.2019” ).
NHANES Questionnaire
Questionnaires are administered to participants in their homes or the mobile examination
centers (MEC) trailers. Questionnaires had different types consisting of
1. Family Questionnaire- Where household information is collected. It consists of the
following sections- consumer behavior, demographic background/occupation, family
questionnaire hand cards, food security, housing characteristics, income, smoking,
tracking and tracing.
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2. Sample Person Questionnaire- Information at the individual level is collected here and
this includes information on demographics, medical conditions, dietary behavior, early
childhood, health insurance, hospital utilization and access to care.
Laboratory Data
This includes findings from urine, blood, vaginal swabs, water samples and oral rinse.
Water samples were obtained from participant homes. Tests were based on the gender and age of
participants. Urine collection was accompanied by pregnancy testing. Before blood was drawn, a
questionnaire was administered to pick out individuals for whom drawing of blood was
contraindicated (“NHANES 2007-2008 Laboratory Data Overview sourced from
https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2007 on
10.28.2019.” )
Data Collection
Automated methods and survey forms were used in the mobile examination centers and
laboratories and subsequently integrated with the main NHANES database. Some analyses were
conducted off-site (“NHANES 2007-2008 Laboratory Data Overview, sourced from
https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2007 on
10.28.2019” )
Sample Weights
In NHANES, data were collected on a nationally representative subsample smaller than
the population it represented. Weights were assigned to account for non-response and additional
stage sampled. Weights are included in the data file, as well as replicate weights needed for the
estimation of sampling error (“NHANES Subsample Notes and Data, sourced from
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https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2007 on
10.28.2019” ). When merging full data files with subsamples files, analytical samples were taken
as sub-samples and as such, subsample weights were used.
Combining Sample Weights
Sample weight combination are described in detail elsewhere (Center for Health
Statistics, 2007). Briefly, to combine cycles to give four-year estimates from two-year estimates,
the two-year weights are divided by 2 to give four-year estimates; similarly, two-year weights
are divided by three to give six-year weights.
Sample Design
NHANES data sample represents the total non-institutionalized US population in the 50
contiguous states of the US and the District of Columbia. A four-stage sampling design was
used. First, primary sampling units (PSU) were selected from a sampling frame comprising all
US counties, mainly individual counties but combination of counties were seldomly done to keep
primary sampling units over a certain minimum level (Center for Health Statistics, 2007) .
Second stage of sampling was done on census blocks or a combination of these. These
areas were based on the 2000 census, therefore, if the population had grown significantly, the
measure of size was updated for primary sampling units that had grown in size significantly
since 2000 (Center for Health Statistics, 2007).
The third stage of sampling consisted of non-institutionalized dwelling units from the
primary sampling units and a sub-sample of these were identified for screening to identify and
produce the required number of participants based on race, Hispanic origin, income, sex, age
domain (Center for Health Statistics, 2007).
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The fourth sampling stage was for members within a house-hold, individuals were
selected based on domains defined by their race, ethnicity, income, sex and age (Center for
Health Statistics, 2007).
Strengths of NHANES Data
•

Nationally representative dataset

•

Publicly available and easy to access

•

Subjects are carefully selected and adequately representative of the US population using a
systematic sampling process

•

Years can be combined to give a larger sample size

•

Can be extrapolated to estimate percent of the US population and sub-groups with
particular diseases and risk factors of disease

•

Monitoring of trends in disease prevalence, awareness, treatment and control

•

Monitoring of trends in environmental exposures

•

Analyzing disease risk factors

•

Exploring the relationship between diet, health and nutrition

•

Investigating new and emerging public health issues

•

Obtaining a base-line health and nutritional status of the United States population
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Limitations of NHANES Data
Cross-sectional nature of the data means causality cannot be established due to temporal
ambiguity; the exposure and disease outcomes are collected simultaneously.
Individuals cannot be followed-up for the exposure or disease condition being
investigated.
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Abstract
Objectives
This study aimed to examine the association of perfluoroalkyl chemical and phthalate exposure
with cardiometabolic conditions and to investigate the possibility of phthalates modifying the
relationship between perfluoroalkyl chemicals and cardiometabolic conditions.
Methods
Using data from the National Health and Nutrition Examination Survey (NHANES), study
participants ≥ 20 years of age were selected. Outcome variables were cardio-metabolic
conditions- general obesity (yes/no), central obesity male (yes/no), central obesity female
(yes/no), hypercholesterolemia (yes/no), systolic hypertension (yes/no), diastolic hypertension
(yes/no), hyperglycemia (yes/no), hypertriglyceridemia (yes/no). Exposure variables were
perfluoroalkyl chemicals (PFCs). Logistic regression models were used to investigate the
relationship between PFCs and the cardio-metabolic health outcomes while adjusting for
covariates-age, sex, education, ethnicity, and income level. An interaction term between PFCs
and phthalates was added to the main effect model to assess the possibility of effect
modification.
Results
Perfluorononanoic acid (PFNA) was associated with increased odds of central obesity in
females, odds ratio (OR: 1.10; 95% CI: 1.01, 1.21). Mono-2-ethyl-5- hydroxy-hexyl phthalate
was associated with increased odds of hypertriglyceridemia (OR:1.01; 95% CI: 1.01, 1.02) and
hypercholesterolemia (OR:1.01; 95% CI: 1.01,1.02). A unit increase in mono-2-ethyl-5hydroxy-hexyl phthalate was associated with a 1% increase in the odds (95% CI: 1.01,1.02) of
being centrally obese in females. Models with built-in interaction terms between PFCs and

30

phthalates were all not significant (P for interaction >0.05) with a reduction in estimates towards
the null.
Conclusion
Individually, perfluoroalkyl chemicals were associated with central obesity in females and
phthalates were associated with central obesity in females and with elevated triglycerides and
cholesterol in both males and females. Phthalates did not modify the relationship between
perfluoroalkyl chemicals and cardio-metabolic conditions.
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Introduction
Perfluoroalkyl compounds (PFCs) are stable human-made chemicals frequently utilized
due to their ability to act as good surfactants with widespread uses in paper, cardboard
packaging, carpeting, leather products, coatings on cookware, fire-fighting foams and clothing,
leading to widespread exposure (Agency for Toxic Substances and Disease Registry (ATSDR),
2018). Use of PFCs may have declined in the United States (U.S.) with mean concentrations of
PFOS, PFOA, PFHS and PFNA decreasing by 32%, 25%, 10% and 100% respectively between
2000-2004 (Calafat, Wong, Kuklenyik, Reidy, & Needham, 2007) when the U.S. Environmental
Protection Agency began phasing out the production of several PFCs (US EPA 2017).
Large amounts of PFCs have been released to the air, soil, sediment, surface water, and
groundwater from production in and around fluoro- chemical facilities, with as much as 10,000500,000 pounds produced per year for perfluorooctanoic acid (PFOA) alone prior to 2002
(ATSDR 2009). This coupled with the environmental persistence resulting from resistance to
biodegradation, direct photolysis, atmospheric photo-oxidation and hydrolysis of these
compounds make PFCs a public health threat today even when its production has been reduced.
For example, the half-life of pfos in water (at 25°C) is greater than 92 years and that of pfoa is
greater than 41 years (US EPA 2018). PFCs that have been measured in the serum of U.S.
residents include but are not limited to PFOA, perfluorononanoic acid (PFNA),
perfluoroundecanoic acid (PFUA), perfluorodecanoic acid (PFDE), perfluorododecanoic acid
(PFDoA), perfluorooctane sulfonic acid (PFOS), and perfluorobutyric acid (PFBA) (Stahl et al
2011). Exposure could differ slightly with the level of industrialization, degree of use of PFCcontaining consumer products, geography, gender, ethnicity, and to a lesser extent, age
(Lindstrom et al 2011). Routes of exposure include inhalation from long-range air transport,
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dermal and oral routes (ATSDR 2009) with diet, particularly seafood, being the major source of
perfluorinated compound exposure in humans (ATSDR 2009; Haug et al 2010).
Endocrine disrupting chemicals such as PFCs have been reported to be positively
associated with the development of obesity through the disruption of hormonal actions and
epigenetic mechanisms (Cock et al 2016). Specifically, PFOA exposure has been associated with
adipocyte proliferation and differentiation as well as an increase in the accumulation of lipids
and triglycerides. Probable mechanisms include increased gene expression of peroxisome
proliferator activated receptor gamma (PPARγ), CCAAT/enhancer, binding proteins α, fatty acid
binding protein 2, and lipoprotein lipase (Ma et al 2018). These result in the development of
increased percentage body fat in some instances and metabolic syndrome, overweight and
obesity (Hartman et al 2017; Yang et al 2018; Lauritzen et al 2018).
In occupationally exposed workers, PFOA exposure was observed to have no clinically
significant hepatic toxicity but was hypothesized to modulate hepatic responses to obesity and
xenobiotics (Gilliland and Mandel, 1996). Perfluoroalkyl substance (PFOA and PFOS) exposure
has also been positively associated with total cholesterol in a middle aged Danish population and
lipid levels in children in the U.S. (Eriksen et al 2013; Geiger et al 2014). Alterations in total
body cholesterol and lipids in general have been linked to cardiovascular diseases and abnormal
blood pressure (Graham et al 2012). Central obesity in particular, which PFCs have been linked
to, has a stronger correlation with cardiovascular disease and mortality compared to general
obesity due to the central fat distribution impeding normal cardiovascular function (Sahakyan et
al., 2015) . Adult onset poor glycemic control is associated with type II diabetes mellitus (AlKhawaldeh et al 2012; Sahakyan et al 2015). With the documented possible interactive effect of
endocrine disruptive chemicals (Papalou et al., 2019), there are plausible mechanisms to expect
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an additive interactive effect of concurrent PFCs and phthalate exposure which this study intends
to assess.
To the best of our knowledge, few studies have examined the associations of PFCs
exposure with general- and central- obesity, and other cardio-metabolic conditions including
hypercholesterolemia, systolic hypertension, diastolic hypertension, hyperglycemia,
hypertriglyceridemia and possible moderation of effect by concurrent phthalate exposure. This is
among the first studies to examine all relationships between exposure to perfluoroalkyl
chemicals, obesity, hypercholesterolemia, hypertriglyceridemia, systolic, diastolic blood pressure
and blood glucose from non-occupationally exposed U.S. adults while at the same time exploring
interactions with phthalates in the human system. We hypothesize that PFCs are positively
associated with general and central obesity, hypercholesterolemia, systolic hypertension,
diastolic hypertension, hyperglycemia and hypertriglyceridemia and this association is
moderated additively by phthalate exposure.
Methods
Study Population
Data (n=17,713, age ≥ 20 years old) were obtained from 2007-2012 National Health and
Nutrition Examination Survey (NHANES). NHANES is a cross sectional survey of noninstitutionalized U.S. population, collecting data and performing laboratory analysis on a subset
of this data (CDC, 2018). This year-group was used because it contained the variables and
biomarkers needed for our data analysis while using similar analytical and laboratory
methodology. During data analysis, participants with missing variables of interest were excluded
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from the analysis. Persons less than 20 years of age were also excluded from the analysis
(n=12729).
Outcome Variables
Outcome variables were categorized as general and central obesity (yes/no),
hypercholesterolemia (yes/no), systolic hypertension (yes/no), diastolic hypertension (yes/no),
hypertriglyceridemia (yes/no), hyperglycemia (yes/no).
The outcome variables were categorized using cut-offs: general obesity (BMI ≥30kg/m²), central
obesity (waist circumference greater than 101.6cm in males and 88.9 cm in females),
hypercholesterolemia (total serum cholesterol greater than or equal to 200mg/dl), systolic
hypertension (systolic greater than 130mmhg), diastolic hypertension (diastolic greater than
80mmhg), hypertriglyceridemia (serum triglycerides greater than or equal to 150mg/dl or
1.68mmol /l), and hyperglycemia (random blood glucose greater than 200mg/dl). Cut-offs were
assigned using the National Cholesterol Education Program, Adult Treatment Panel III (NCEP
ATPIII) and World Health Organization (WHO) 1998 criteria (Huang 2009).
A computer-assisted personal interviewing system was used to obtain information from
participants in their homes. Anthropometric measures were obtained on examination in a mobile
examination center (CDC 2018). BMI was obtained using weight in kilograms divided by height
in meters squared. Waist circumference was obtained by positioning the subjects, marking the
measurement site, extending the measuring tape around the waist and recording the result. Blood
pressure was measured using a mercury sphygmomanometer around the right arm preferably.
Details have been described elsewhere (CDC 2018).
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Total cholesterol, triglycerides, and serum glucose were measured using Roche Modular P
chemistry analyzer while perfluoroalkyl compounds were analyzed using solid phase extraction
coupled to High performance Liquid Chromatography-Turbo Ion Spray ionization-tandem mass
spectrometry, with more details being described elsewhere (CDC 2018). Briefly, a 100 microliter
of serum is diluted with formic acid and injected into a commercial column switching system
allowing for concentration and chromatographic separation of the analytes. Quantitative
phthalate detection in urine was assayed using high performance liquid chromatographyelectrospray ionization-tandem mass spectrometry.
Exposure Variable: PFCs Exposures
Highly detectable PFCs with greater than 94% detection rate were focused on including
PFDE, PFOS, PFHS, PFNA, and PFOA. Samples below the limit of detection were assigned a
value of the limit of detection divided by the square root of 2 (CDC 2018). Models including a
phthalate metabolite were adjusted for urinary creatinine. Urinary phthalate metabolites included
in the analysis were mono-ethyl phthlate, mono-n butyl phthalate, mono-isobutyl phthalate,
mono benzyl phthalate, mono 3 carboxy propyl phthalate, mono 2 ethyl hexyl phthalate, mono2
ethyl 5 hydroxyhexyl phthalate, mono-2-ethyl-5-carboxylpentyl phthalate, mono-2 ethyl-5-oxo
hexyl phthalate. The latter four have as their parent compound di-2-ethylhexyl phthlate.
Covariates
Covariates included age (continuous variable), sex (female and male), ethnicity
(Hispanic-Mexican American, Hispanic-Other Hispanic, Non-Hispanic Black, Non-Hispanic
White, and Other), education level (less than 9th grade, 9-11th grade, high school grad/GED or
equivalent, some college or AA degree, and college graduate or above), and Poverty-Income
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Ratio (PIR) (continuous variable, calculated by dividing family income by the poverty guidelines
which are specific to family size in the respective state for that particular year) (CDC 2018).
Statistical Analysis
Descriptive statistics comprising of participants’ demographics and the distribution and
concentrations of biomarkers were calculated and summarized. Correlations were assessed
between exposure variables using Spearman and Pearson correlation coefficients Logistic
regression analyses were used to assess the relationship between PFCs and outcome variables
(obesity; central obesity; hypercholesterolemia; systolic hypertension; diastolic hypertension;
hyperglycemia modelled and hypertriglyceridemia. ) while adjusting for covariates (age, sex,
race/ethnicity, income and education ). Models that included phthalates were additionally
adjusted for urinary creatinine. First, main effect models of PFCs and phthalate were built and
assessed and then models which included additive interactions between PFCs and phthalates
were then included in our models and analyzed. Our dependent variables were general obesity
modelled as normal (1), obese (2); central obesity modelled as normal (1), obese (2);
hypercholesterolemia modelled as yes (2), no (1); systolic hypertension modelled as yes (2), no
(1); diastolic hypertension modelled as yes (2), no (1); hyperglycemia modelled as yes (2), no (1)
and hypertriglyceridemia modelled as yes (2), no (1). Covariates (i.e., gender, race/ethnicity and
education) were included in models as categorical variables. The first category was taken as the
reference category and this was Mexican American for ethnicity, males for gender and less than
ninth grade for education. Age, family income to poverty ratio (PIR), perfluorinated chemical
substances, phthalate and urinary creatinine concentration were modelled as continuous
variables. Binary logit with the fisher scoring sysytem was used for optimization. The models
with intercept and covariates fit better than the intercept-only model. . Interactions between PFCs
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and phthalate metabolites were explored using the Baron and Kenny’s and MacArthurs approach
(Kraemer, Kiernan, Essex, & Kupfer, 2008).
Mobile Examination Centers (MEC) sample weights corresponding to the smallest sub-groups
were identified and combined based on criteria described elsewhere (“NHANES Tutorials Module 3 - Weighting,” Sourced from https://wwwn.cdc.gov/nchs/nhanes/tutorials/module3.aspx
on 02.06.2020.). However, exclusion of sample weights was done in a few models because when
variables used in the calculation of sample weights (e.g., ethnicity and age groups) were included
in these models, a weighted analysis decreased the effect estimate in this study and/or obliterated
the confidence intervals and this has also been noted and suggested in other studies (Kon and
Graubard, 1991). An alpha level of 0.05 was used to establish statistical significance. All the
statistical analyses were performed using SAS version 9.4 and IBM SPSS Statistic version 25.
Results
Table 2.1 shows the demographics of subjects from NHANES 2007-2012. The mean
age was 49.79±17.92 years. The average BMI was 28.98 (± 6.80). A slight majority of subjects
had some college or AA degree (27.7%) and a higher percentage of participants were NonHispanic White (43.9%). A higher percentage had non-elevated random blood glucose
(96.8%), normal cholesterol levels (57.1%), normal triglyceride levels (62.5%), normal
diastolic (76.3%), and normal systolic blood pressure (66.0%).
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Table 2.1.
Demographic Characterisitics of Study Participants (n=17,713)
Variable
n (%)
Mean (S.D.)
Age (years)
49.79(±17.92)
Sex
Males
8656(48.9)
Females
9057(51.1)
BMI (kg/m2 )
28.98(± 6.80)
Waist Circumference (cm)
Females ≤88.9 (non-centrally obese)
2779(34.0)
Females >88.9(centrally obese)
5394(66.0)
Males ≤101.6 (non-centrally obese)
4393(55.7)
Males > 101.6 (centrally obese)
3496(44.3)
Education
Less than 9th grade
2132(12.0)
9th -11th grade
2837(16.0)
High School grad/ GED or equivalent
4057(22.9)
Some college or AA degree
4904(27.7)
College Grad or Above
3756(21.2)
Refused
9(0.1)
Don’t Know
18(0.1)
Poverty-Income-Ratio
2.45(±1.63)
Race/ethnicity
Mexican American
2713(15.3)
Other Hispanic
1876(10.6)
Non-Hispanic White
7778(43.9)
Non-Hispanic Black
3804(21.5)
Other/multi-racial
1542(8.7)
Random Blood Glucose
≥200mg/dl
514(3.2)
<200mg/dl
15373(96.8)
Triglycerides
≥ 150mg/dl
5958(37.5)
<150mg/dl
9915(62.5)
Blood Pressure
Average Diastolic ≥80mmhg
3719(23.7)
Average Diastolic <80mmhg
11994(76.3)
Average Systolic ≥ 130mmhg
5350(34.0)
Average Systolic <130mmhg
10363(66.0)
Total Cholesterol
≥200mg/dl
6834 (42.9)
<200mg/dl
9107 (57.1)
Abbreviations: S.D, standard deviation; AA, associate degree; BMI, body mass index; GED, general education
development
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Table 2.2 presents the serum distribution of PFC biomarkers. Overall, 94.0%,
99.0%, 99.4%, 99.7%, and 99.7% of our participants blood samples had PFDE, PFHS,
PFNA, PFOA, and PFOS above the minimal level of detection and each had a median
serum concentration of 0.26, 1.60, 1.07, 3.10, 10.10 ng/ml and maximum concentration
of 25, 82, 81, 104, 281 ng/ml respectively.
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Table 2.2
Serum Concentrations of PFCs (ng/ml), NHANES 2007-2012 (n=5,172)
Analyte

LOD

n (%)

BY

>LOD

Percentiles

CYCLE
mean

10th

50th

75th

90th

95th

Max

4864(94.0)

0.29

0.10 0.16 0.29

0.40

0.70

0.97

25

0.10

5118(99.0)

1.60

0.48 0.90 1.60

2.73

4.60

6.60

82

0.08

0.08

5143(99.4)

1.15

0.54 0.75 1.15

1.67

2.59

3.36

81

0.10

0.10

0.10

5156(99.7)

3.00

1.25 1.97 3.00

4.70

6.70

8.10

104

0.20

0.20

0.20

5158(99.7)

10.20

3.20 5.74 10.20 17.10 28.30 38.43 281

07-08

09-10

11-12

PFDE

0.20

0.10

0.10

PFHS

0.10

0.10

PFNA

0.08

PFOA
PFOS

25th

Abbreviations: LOD, limit of detection; PFDE, Perfluorodecanoic acid; PFHS, Perfluorohexane sulfonic acid;
PFNA, Perfluorononanoic acid; PFOA, Perfluorooctanoic acid; PFOS, Perfluorooctane sulfonic acid.

Tables 2.3 and 2.4 represents the odds ratios (ORs) and 95% confidence intervals (CIs) for
the association between PFCs and the various cardiometabolic conditions. Statistically significant
associations were noticed between PFNA and central obesity in females. Among females, one ng/ml
increase in PFNA was associated with 10% increased odds of being centrally obese (OR: 1.10; 95%
CI: 1.01, 1.21). In addition, there was a 9% (OR: 1.09 (CI: 1.00,1.20) and 2 % (OR: 1.02(CI: 1.0,1.04)
suggestively significant increase in the odds of developing hypercholesterolemia and
hypertriglyceridemia per unit increase in concentrations of PFDE and PFOA respectively
(0.05>p<0.1) with PFHS and PFOA showing weakly protective associations from hyperglycemia
(0.05>p<0.1).

Table 2.3.
Association between PFCs Exposure and General and Central Obesity

PFCs
Analyte

General Obesity
(measured by BMI)

Central Obesity
Central Obesity
(Male)
(Female)
(measured by WC) (measured by WC)
PFHS
0.991(0.957,1.026)
1.004(0.981,1.027) 0.973(0.930,1.017)
PFNA
1.074(0.982,1.175)
0.955(0.891,1.023) 1.103(1.007,1.208)**
PFOA
1.005(0.964,1.048)
0.971(0.943,1.001)* 1.011(0.969,1.055)
PFOS
0.995(0.989,1.001)
0.996(0.990,1.001) 1.003(0.993,1.012)
PFDE
0.876(0.738,1.039)
0.700(0.550,0.892) 0.999(0.754,1.324)
PFCs, Perfluorochemical substance; PFDE, Perfluorodecanoic acid; PFHS, Perfluorohexane
sulfonic acid;
PFNA, Perfluorononanoic acid; PFOA, Perfluorooctanoic acid; PFOS, Perfluorooctane sulfonic
acid.
**significant at p<0.05.*trending towards significance 0.05<p<0.1
Central Obesity: waist circumference greater than 101.6cm in males and 88.9 cm in females

Table 2.4
Association between PFCs Exposure and other Cardio-Metabolic Conditions

Analyte

PFHS

PFNA

PFOA

PFOS

PFDE

Hyper-

Systolic

Diastolic

Hyperglycemia

Hypertriglyceridemia

cholestorolemia

Hypertension

Hypertension

1.006(0.987,1.026)

1.018(0.996,1.041)

1.003(0.982,1.026)

0.917(0.832,1.012)*

1.003(0.984,1.023)

1.028(0.988,1.069)

0.988(0.949,1.029)

0.988(0.944,1.034)

0.871(0.718,1.057)

1.000(0.961,1.040)

1.012(0.992,1.032)

1.000(0.978,1.023)

1.000(0.978,1.022)

0.920(0.842,1.006)*

1.021(1.000,1.042)*

1.002(0.998,1.006)

1.002(0.997,1.006)

1.001(0.996,1.005)

0.998(0.986,1.009)

1.000(0.996,1.004)

1.094(0.993,1.205)*

1.082(0.984,1.190)

1.017(0.927,1.116)

0.960(0.696,1.325)

1.002(0.918,1.094)

PFC, Perfluorochemical; PFDE, Perfluorodecanoic acid; PFHS, Perfluorohexane sulfonic acid;
PFNA, Perfluorononanoic acid; PFOA, Perfluorooctanoic acid; PFOS, Perfluorooctane sulfonic
acid.
*0.05<p<0.1 trending towards significance

In models with phthalates as the exposure variable (table not shown), mono-2-ethyl-5hydroxy-hexyl phthalate was associated with 1% increased odds of hypertriglyceridemia (OR:1.01;
95% CI: 1.01, 1.02) and hypercholesterolemia (OR:1.01; 95% CI: 1.01,1.02). A unit increase in
mono-2-ethyl-5- hydroxy-hexyl phthalate was associated with a 1% increase in the odds (95% CI:
1.01,1.02) of being centrally obese in females. Models with built-in interaction terms between PFCs
and phthalates were all not significant (P for interaction >0.05) with a reduction in estimates towards
the null.
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Discussion
This is one of a few studies that aimed to explore the associations between PFCs
exposure and general- and central- obesity and other cardio-metabolic conditions using a
nationally representative U.S. adult population. Our major findings include positive
associations between specific PFCs exposures and our outcome variables. PFCs and phthalates
exposures were associated with central obesity in females, hypercholesterolemia and
hypertriglyceridemia. PFCs and phthalate exposure occur frequently during use of several
household and workplace products therefore exposure to any one of these products could
potentially lead to development of obesity in females, and cholesterol and triglyceride
abnormalities as individual substances with no evidence, from our analysis, for any additive
interactive effect between these two compounds in causing morbidity.
Our finding of elevated serum total cholesterol with PFDE was similar to results
investigating dyslipidemias in adolescents using NHANES data from 1999-2008 which
concluded that serum PFOA and PFOS levels were positively associated with high total
cholesterol and low density lipoprotein cholesterol (Liu et al., 2018) Possible explanations
being the effect of PFCs on PPARγ and the CCAAT gene motifs (Ma et al., 2018). Unlike the
Liu et al.’s study that found serum total and linear PFOS were associated with less hypertriglycerides, our study showed a suggestively significant increased odds of having elevated
triglycerides with an increase in PFOA similar to findings by Christensen et al. (2019) whom also
noted elevated levels of triglycerides with increased levels of PFHxS (Christensen, Raymond, &
Meiman, 2019). These discrepancies may be attributable to differing toxicokinetics that have been
noticed between linear and branched PFCs (Liu et al., 2018).
In this study we noticed slightly reduced odds of having hyperglycemic episodes with
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increased exposures to PFCs. This could have arisen from the increased beta cell function and
increased insulin levels that have been ascribed to PFCs exposure particularly linear PFOA and
branched PFOS (Liu et al., 2018), (Lin, Chen, Lin, & Lin, 2009). An increase in beta cell function and
insulin levels helps drive glucose from the peripheral circulation into cells of tissues and organs that
metabolize glucose.
We examined the association between PFCs and obesity and noticed increased odds of
central obesity in females but not males on exposure to PFNA. These has been noted in studies
by Liu et al in the U.S that sought to explore weight regain among persons who had lost
weight following diet changes. The trial noted weight regain following PFCs exposure
especially among women, an effect attributed to the slower regression of metabolic rate in
women (Liu et al., 2018).
Phthalates which are known endocrine disruptors have been linked with obesity,
metabolic syndrome and other diseases through their perturbation of normal hormonal
homeostasis involving cell signaling and glucose control. Slightly increased odds of central
obesity in females, hypercholesterolemia and hypertriglyceridemia were noted in this study.
Studies have also linked monobutyl phthalate, mono-2-ethyl hexyl phthalate and central
obesity (Yaghjyan, Sites, Ruan, & Chang, 2015). A reason for the predilection for central
obesity in females may be due to the relatively slower oxidative conversion of some of the
phthalate (DEHP) metabolites which have been associated with higher BMI such as mono-2ethyl hexyl phthalate in females (Yaghjyan et al., 2015). Studies in the literature have linked
di-ethyl-hexyl phthalate with the development of obesity and type II diabetes as well
(Stojanoska, Milosevic, Milic, & Abenavoli, 2017).

This study found no association between phthalates and systolic or diastolic blood
45

pressure in contrast to a study done in China that did find an association between DEHP and
systolic blood pressure and between bis (2-nbutoxyethyl) phthalate (DBEP), di-butylphthalate (DBP) and elevated cholesterol levels which were similar to our findings (Zhang et
al., 2018). We noticed increased odds of elevated triglycerides when compared to normal
levels of triglycerides with mono-2-ethyl-5-hydroxyjexyl phthalate. This could be due to
increased genetic expression of fatty acid metabolism-related genes in the hepatic HepG2
cells such as SREBP-1c, ChREBP and the decreased expression of genes such as FASN and
SCD (Bai et al., 2019).
We found no significant interactions between PFCs and phthalates in modifying either
exposure’s effect on obesity, hypertriglyceridemia and hypercholesterolemia possibly due to
their varying mechanisms of action. Endocrine disruption may occur through estrogen-related
receptors, nuclear receptors and through the Ras pathway from activation of targets in the
cytosolic milleu and therefore vary across different exposure chemicals through various
changes in hormonal metabolism and in the perturbation of the normal hormonal feedback
process or through DNA/histone modifications to name a few (De Coster & Van Larebeke,
2012). PFCs are associated with central obesity in females and phthalates are associated with
central obesity in females, hypercholesterolemia and hypertrygliceridemia. Exposure to these
chemicals by use of products containing them or through ambient or occupational exposures
as is the case with PFCs would put the public at risk of obesity, elevated cholesterols and
elevated triglycerides which are all risk factors for chronic diseases especially cardiovascular
diseases.

The study has some limitations. First, being a cross-sectional study, causality cannot be
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established due to temporal ambiguity. Second, measurement errors could have arisen from
single blood sample collection, which, if present, could result in non-differential classification
biasing our effect estimates and associations towards the null. However, this analysis presents
some useful contribution to the state-of-the-science as it may be among the first studies to
actually make comparisons between general and central obesity by exposure to PFCs as well as
other cardio-metabolic conditions while also checking for potential effect modification by
phthalates.

Conclusion
PFCs exposures were associated with central obesity in females only. Phthalate exposure
was also associated with central obesity in females, hypercholesterolemia and hypertriglyceridemia.
Further longitudinal studies with large sample sizes are warranted to confirm the results of this
study.
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Abstract
Objectives
This study aimed to examine the association of perfluoroalkyl chemicals (PFCs) and markers of
chronic inflammation and oxidative stress.
Methods
Using data from the National Health and Nutrition Examination Survey (NHANES), Generalized
Linear Models were used to examine association between PFCs and inflammatory (ferritin,
alkaline phosphatase, C-reactive protein, absolute neutrophil count and lymphocyte count) and
oxidative stress (serum bilirubin, albumin and iron) markers per unit exposure to PFCs while
adjusting for covariates. Study participants were those ≥ 20 years of age. Outcome variable were
markers of chronic inflammation and oxidative stress and exposure variables were perfluoroalkyl
chemicals. Models were adjusted for covariates.
Results
Perfluorohexane sulfonic acid (PFHS), Perfluorononanoic acid (PFNA), Perfluorooctanoic acid
(PFOA), Perfluorooctane sulfonic acid (PFOS), and Perfluorodecanoic acid (PFDE) were all
significantly associated with increased lymphocyte counts, Beta (95% confidence interval),
B(CI); 0.04(0.02,0.05), 0.04(0.02,0.05), 0.05(0.03, 0.07), 0.04(0.03,0.05), 0.03(0.13,1.23) and
with increased serum iron 0.07(0.05,0.09), 0.04(0.02,0.07), 0.10(0.07,0.12), 0.05(0.03,0.07),
0.04(0.02,0.06) and increased serum albumin 0.02(0.02,0.02), 0.02(0.02,0.03), 0.03(0.03,0.04),
0.02(0.017, 0.025), 0.01 (0.01, 0.05). Only PFHS, PFNA, PFOA and PFOS were associated with
serum total bilirubin 0.04(0.03,0.05), 0.02(0.00,0.03), 0.06(0.04,0.08), 0.03(0.02,0.05). Similar
results were obtained for categorical quintile analysis with PFOA showing a significant trend
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(P<0.001) with lymphocyte count, serum iron, serum total bilirubin and serum albumin. Trend
for neutrophil count was not significant (p=0.183).
Conclusion
Perfluoroalkyl chemicals are associated with markers of chronic inflammation and oxidative
stress. Increased exposure leads to increase in serum concentration of these markers meaning
these chemicals are associated with both chronic inflammation and oxidative stress.
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Introduction

Perfluoroalkyl chemical substances (PFCs) are stable human-made chemicals that are
frequently used in durable consumer goods due to their ability to act as good surfactants. PFCs
have widespread uses in paper and cardboard packaging, carpeting, leather products, coatings on
cookware, fire-fighting foams and clothing . PFCs that have been detected in the blood of
humans include perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA),
perfluoroundecanoic acid (PFUA), perfluorododecanoic acid (PFDoA), perfluorooctane sulfonic
acid (PFOS), perfluorobutyric acid (PFBA) perfluorohexane sulfonate (PFHxS) (Atsdr, 2018),
(Lindstrom, Strynar, & Libelo, 2011a).
PFCs are known for their neurologic, metabolic, hormonal, inflammatory, immunologic
and developmental pathologies which are mainly chronic. Studies linking PFCs to delayed
menarche (Wu et al., 2015), (Kristensen et al., 2013), reproductive hormones and increased
thyroid hormone in females (Lewis, Johns, & Meeker, 2015) , (Berg et al., 2015), (Wang et al.,
2013), increased total cholesterol, increased low and high density lipoprotein, increased
triglycerides (Zeng et al., 2015), (Starling et al., 2014), attention deficit hyperactivity disorder
and cerebral palsy (Liew et al., 2014), (Liew et al., 2015) have been noted. PFCs have also been
linked with changes in total bilirubin concentration in the blood and also with uric acid, alanine
transferase and gamma-glutamyl transferase (Gleason, Post, & Fagliano, 2015). Other health
effects including sperm DNA methylation (Leter et al., 2014), diabetes (Lind, Zethelius,
Salihovic, van Bavel, & Lind, 2014), liver cancer and cirrhosis (Yeung et al., 2013) have also
been documented.
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Inflammation can either be acute or chronic. Acute inflammation is defined as a transient
and early response to injury involving the release of chemical mediators resulting in
characteristic small vessel and leukocyte, primarily neutrophil, responses (Goljan, 2014).
Neutrophils are the primary cells involved in acute inflammation (Goljan, 2014). Absolute
neutrophil count (ANC) has widely been used as a biomarker for infection, the acute phase of
inflammation and more recently environmental exposures (Kubesch et al., 2015). Chronic
inflammation is defined as prolonged inflammation lasting weeks to years that most often results
from persistence of an injury causing agent. The primary cells responsible are monocytes and
macrophages along with lymphocytes, plasma cells and eosinophils (Goljan, 2014). Monocytes
and lymphocytes do play a crucial role in humoral immunity and pathologic processes and the
evaluation of blood films is an important screening tool for differentiating between reactive
(inflammatory) and the malignant pathologic processes in lymphocytosis (Sun et al., 2014).
Inflammation has a crucial role to play in a variety of diseases such as atherosclerosis (RafieianKopaei et al., 2014), (McKibben et al., 2015), heart failure (Glezeva et al., 2015a), hemolysis in
sickle cell disease patients (Wongtong, Jones, Deng, Cai, & Ataga, 2015a), poor prognosis in
patients with cancers (P. Hu et al., 2014a) and coronary artery disease (Shantsila et al., 2014a) .
Oxidative stress is a biological phenomenon that occurs when there is a disruption in the
equilibrium between oxidants and anti-oxidants in favor of the oxidants leading to a disruption in
redox signaling and/or molecular damage (H Sies & Jones, 2007). It results in damage to
macromolecules (e.g., proteins and deoxyribonucleic acid) due to reactive oxygen species as a
result of inefficiency of cellular anti-oxidant systems. Inflammation and oxidative stress give an
insight into the pathological basis of a good number of disease processes. When there is
oxidative stress, the human body’s adaptive mechanism is to respond to this stress by production
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of anti-oxidant molecules or enzymes (Sies, 2015). Bilirubin is an antioxidant with marked antioxidant properties whose elevation has been found to have direct correlation with lipid prooxidant activity, and thus intensification of reparative processes in organs such as the liver which
can help to prevent potential injury (Bliuger, Dudnik, Maĭore, & Mieze, 1985), (Hamoud,
Weaver, Stec, & Hinds, 2018). Albumin is a negative acute-phase reactant and has extracellular
anti-oxidant properties (Sitar, Aydin, & Cakatay, 2013). Alkaline phosphatase, ALP has widely
been used as a marker of hepatobiliary and skeletal function, more recently it has been employed
as an inflammatory marker of atherosclerosis and peripheral vascular disease and comparisons
have been drawn with CRP (Webber, Krishnan, Thomas, & Cheung, 2010).
Environmental chemical exposures such as phthalates have been found to have an
association with markers of inflammation and oxidative stress in humans (Ferguson, McElrath,
Chen, Mukherjee, & Meeker, 2015), (Franken et al., 2017). Exposure could differ slightly with
the level of industrialization, degree of use of PFC-containing consumer products, geography,
gender, ethnicity and to a lesser extent, age (Lindstrom, Strynar, & Libelo, 2011b). There has
been a corresponding decrease in the blood levels of PFOS and PFOA in the U.S. arising due to
regulatory pressures to reduce production, but levels of other PFCs like PFNA and PFHxS have
increased suggesting that there may yet be sources of exposure not accounted for (Lindstrom et
al., 2011b). However, due to resistance to biodegradation, direct photolysis, atmospheric photooxidation and hydrolysis, the potential health effects these compounds pose remains considerable
(Andrés-Blasco et al., 2015).
Though there have been animal studies looking at PFC exposure and biomarkers of
inflammation and oxidative stress, to the best of our knowledge, there is a paucity or lack of
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studies that have examined relationships between PFC exposure and biomarkers of
inflammation, as well as oxidative stress.
Methods
Participants
Data from multiple cycles of the National Health and Nutrition Examination Survey
(NHANES), which is a representative cross-sectional bi-annual survey of non-institutionalized,
civilian U.S. residents (2005-2012) (“NHANES - About the National Health and Nutrition
Examination Survey,” sourced from www.cdc.gov on 12.01.2019.), served as the data source for
this study. Data were analyzed from a subset of men and women aged ≥20 years who had
measured serum PFCs levels and had the variables of interest (n =6,652). Participants without the
exposure variables and who were less than 20 years of age were excluded from the analysis.
Outcome Variables
Outcome variables include bilirubin, ferritin (2005-2006 cycle only), lymphocyte count,
absolute neutrophil count, alkaline phosphatase, c-reactive protein, albumin and serum iron.
Exposure variables
PFCs exposure variables include PFHS, PFNA, PFOA, PFOS and PFDE.
Covariates
Covariates adjusted for in the models include age, sex, education, ethnicity, income level,
cotinine and body mass index (BMI). All exposure variables were modeled as continuous
variables. Sex was modelled as dichotomous, race/ethnicity, and education were modeled as
categorical variables. Specifically, race consisted of Mexican American, Other Hispanic, Non71

Hispanic White, Non-Hispanic Black, Other-Race. Education comprised less than 9th grade, 9th11th grade, high school graduate or equivalent, some college or associate degree and college
graduate or greater. Age, income level, cotinine and body mass index were modelled as
continuous variables. All models included the same covariates for consistency.
Demographic Data and Body Measurements
The survey utilized Computer-Assisted Personal Interviewing (CAPI) to obtain
demographic information from participants concerning race/ethnicity and education level.
Trained technicians assisted in measuring height and weight in Mobile Examination Centers with
the assistance of a recorder during body measures. Body Mass Index (BMI) values were
calculated using weight in kilograms divided by height in squared meters (“NHANES - About
the National Health and Nutrition Examination Survey,” sourced from www.cdc.gov on
12.01.2019.)
Laboratory Measurements
Blood samples were collected from participants at the mobile examination center,
processed, and shipped to the CDC laboratories for analysis. Samples were analyzed for PFCs
and biomarkers of inflammation and oxidative stress. Our analysis focused on PFCs detected in
>95% of participants, including PFOA, PFOS, PFHS, PFDE and PFNA. Serum PFCs
biomarkers were detected and measured using solid phase extraction coupled to High
Performance Liquid Chromatography-Turbo Ion Spray ionization-tandem mass spectrometry.
Details of laboratory methodology have been described in details elsewhere (“NHANES 20072008 Laboratory Data Overview,” Sourced from www.cdc.gov on 12.01.2019). Serum PFCs
biomarkers below the limits of detection (LOD) were assigned a value of LOD divided by the
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square root of 2. LODs by NHANES cycle (2005-2006, 2007-2008, 2009-2010, 2011-2012)
were reported.
Statistical analysis
Descriptive statistics of participant demographics and concentration of biomarkers were
conducted. Only biomarkers of PFCs exposure detected in greater than 95% of the samples
(PFOA, PFOS, PFHS, PFDE and PFNA) were analyzed. Generalized linear regression models
were used to examine the association between the exposure and outcome variables. Log
transformation of outcome and exposure variables were done to achieve fulfill model
assumptions. Associations between PFCs level and outcome measures were first assessed using
Pearson correlation and simple linear models. These same associations were examined using
generalized linear regression models adjusted for age, gender, BMI, race/ethnicity, education,
poverty income ratio (PIR), and serum cotinine. These covariates were considered and included
in final models due to their significant associations with the outcome variable and based on
previous studies (Kato et al., 2014), (Gómez-Canela, Fernández-Sanjuan, Farrés, & Lacorte,
2015),(Lewis et al., 2015).
We assessed non-linear relationships by regressing markers of inflammation on quintiles
of exposure biomarkers. We used MEC sample weights corresponding to 8 survey years by
multiplying 0.25 by WTMEC2YR for survey cycle 2005-2012. To facilitate interpretation of the
beta coefficients when biomarker concentration was modeled as a continuous variable, one
percentage change in exposure variable results in 100(1.01ᴮ¹-1) percentage change in the
outcome variable while holding all other variables constant. For betas less than 10, 100(1.01ᴮ¹-1)
can be approximated as β1. All statistical analyses were performed using SAS 9.4 and IBM
SPSS Statistics version 25 for windows.
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Results
Table 3.1 shows demographic characteristics of participants (n=6,652) from NHANES
2005-2012 included in our study. Overall, participants had a mean age of 49.4 (±18.07) years,
were predominantly in the overweight/obese category (66%), moderately educated (some
college/ associate degree, 28%) and non-Hispanic White (47%) with a majority having little to
no second-hand smoke exposure (71%).
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Table 3.1
Demographic Characteristic of Study Participants NHANES 2005-2012

Participants (n=6652)
Variable

n (%)

Age (years)

Mean

49.40 (±18.07)

BMI (kg/m2) ᵃ
<18.50 (underweight)
18.50-24.99 (normal weight)
>25.00 (overweight/obese)

112 (1.75)
2,077(32.39)
4,224(65.87)

Education
Less than 9th grade
9th -11th grade
High School grad/ GED or
equivalent
Some college or AA degree
College Grad or Above
Refused
Don’t Know

817(12.28)
1,033(15.53)
1,455(21.87)
1,889(28.40)
1,447(21.75)
3(0.05)
8(0.12)

Race/ethnicity
Mexican American
Other Hispanic
Non-Hispanic White
Non-Hispanic Black
Other/multi-racial

1,088(16.4)
597(9.0)
3,094(46.5)
1,358(20.4)
515(7.7)

Serum cotinine, nmol/l (ng/ml)
<5.68 (1) (no or little STS
exposure)
5.68-56.8 (1-10) (high STS
exposure)
>56.8 (10) smoker)

4,738(71.24)
277 (4.16)
1636(24.60)

Missing values in sub-sample for BMI=239, Serum cotinine=1. Abbreviations: AA,
associate degree; BMI, body mass index; GED, general education development; STS,
secondhand tobacco smoke. ᵃ categories defined based on World Health Organization
BMI classification criteria.
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Table 3.2 shows the distribution of serum PFC concentrations. The median serum concentration for PFDE, PFHS, PFNA, PFOA, and PFOS
were 0.30, 1.60, 1.10, 3.20, and 11.40, respectively. Maximum values ranged from 25.0 to 281.0 for the respective PFCs. Crude analysis using
correlations and regression to examine the relationships between PFC and biomarkers of inflammation and oxidative stress revealed statistically
significant (p<0.001) associations in both the unadjusted (not shown) and adjusted models.
Table 3.2
Serum Concentrations of PFCs (ng/ml) NHANES 2005-2012 (n=6,652)

Analyte

LOD
BY
CYCLE
05-06

07-08

N (%) >LOD

09-10

Percentiles

90th

11-12
median

10

th

25

th

50

th

75

95th

th

Max

PFDE

0.20

0.20

0.10

0.10

6344(95.4)

0.30

0.13

0.16

0.30

0.42

0.74

1.10

25.0

PFHS

0.10

0.10

0.10

0.10

6538(98.3)

1.60

0.44

0.90

1.60

2.80

4.61

6.60

82.0

PFNA

0.10

0.08

0.08

0.08

6599(99.2)

1.10

0.50

0.74

1.10

1.65

2.60

3.39

81.0

PFOA

0.10

0.10

0.10

0.10

6628(99.6)

3.20

1.28

2.00

3.20

4.90

7.10

8.90

104.0

PFOS

0.20

0.20

0.20

0.20

6635(99.7)

11.40

3.60

6.45

11.40

19.68

32.30

42.70

281.0

Abbreviations: LOD, limit of detection.

Generalized linear regression results are presented in Tables 3.3 and 3.4 showing a percentage increase or decrease in outcomes (markers of
inflammation and oxidative stress) associated with one percentage unit change in exposure variable. Overall in adjusted models in tables 3.3 and

3.4, PFHS, PFNA, PFOA, PFOS, PFDE were all associated with statistically significant increases in lymphocyte count, serum total bilirubin
(except PFDE), serum albumin and serum iron concentration. A percentage increase in PFNA and PFDE was associated with a
Table 3.3
Association between PFCs and Chronic Inflammation and Oxidative Stress Markers¹

PFCs

Ferritin

ALP

CRP

Percent Change

Percent change

Percent change

(CI)

(CI)

(CI)

Absolute neutrophil count

Lymphocyte Count

Percentage change (CI)

Percent change
(CI)

PFHS

-0.028(-0.072,0.016)

-0.002(-0.014, 0.01)

-0.064(-0.1,-0.017)**

-0.022(-0.036,-0.007)**

0.036(0.023,0.049)**

PFNA

0.000(-0.066,0.067)

-0.016(-0.032,0.000)**

0.034(-0.028,0.097)

-0.027(-0.047,-0.008)**

0.035(0.018,0.052)**

PFOA

0.008(-0.058,0.073)

-0.014(-0.031,0.003)

-0.049(-0.115,0.016)

-0.04(-0.06,-0.02)**

0.048(0.030,0.066)**

PFOS

0.012(-0.052,0.076)

-0.007(-0.020,0.007)

-0.001(-0.054,0.052)

-0.017(-0.033,-0.000)**

0.039(0.025,0.054)**

PFDE

-0.033(-0.096,0.030)

-0.020(-0.035,-0.005)**

0.006(-0.053,0.065)

-0.025(-0.043,-0.007)**

0.025(0.011,0.040)**

¹ Calculated with coefficients from full generalized linear regression models adjusted for age, sex, race, educational, poverty income
ratio and serum cotinine. CRP= c reactive protein, **=significant at p<0.05, CI=confidence interval, ALP= Alkaline Phosphatase
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slight statistically significant percentage decrease (β: - 0.02%; 95% CI: -0.03, 0.00%) and
(β: -0.02%; 95% CI:-0.04,-0.005) respectively in serum alkaline phosphatase. One percentage
change in all PFCs were associated with statistically significant percentage decreases in absolute
neutrophil counts ranging from 0.02-0.04% keeping all other variables constant. Also, one
percentage change in PFCs resulted in a statistically significant 0.03 to 0.05 percentage increase
in lymphocyte count keeping all other variables constant.
Similar results were obtained for log transformed serum iron, bilirubin and albumin. A
percent change in PFCs resulted in statistically significant percentage increase in serum iron
ranging from β: 0.04%-0.10% while keeping all other variables constant. Also, a percent change
in PFCs resulted in statistically significant percentage increase in serum total bilirubin ranging
from β: 0.04%-0.10% while keeping all other variables constant and a percent change in PFCs
resulted in statistically significant percentage increase in serum albumin ranging from β: 0.02%0.03% while keeping all other variables constant.

Table 3.4
Association between PFC and Chronic Inflammation and Oxidative Stress Markers ¹
PFCs

Serum Iron

Bilirubin

Albumin

Percent change

Percent Change

Percent Change

(CI)

(CI)

(CI)

PFHS

0.07(0.05,0.086)**

0.04(0.025,0.053)**

0.018(0.015,0.02)**

PFNA

0.04(0.018,0.067)**

0.02(-0.00,0.03)*

0.024(0.019,0.028)**

PFOA

0.10(0.074,0.124)**

0.06(0.036,0.076)**

0.03(0.027,0.036)**

PFOS

0.05(0.029,0.07)**

0.033(0.017,0.05)**

0.02(0.017,0.025)**

PFDE

0.04(0.018,0.064)**

0.014(-0.00,0.032)

0.01(0.01,0.052)**

¹ Calculated with coefficients from full generalized linear regression models adjusted for age,
sex, race, educational, poverty income ratio, serum cotinine, BMI.**p<0.05, CI= confidence
interval

Figure 3.1 and 3.2 show results from selected adjusted quintile categories of PFOA
regressed against serum concentrations of the markers of inflammation and oxidative stress. To
investigate the possibility of non-linear relationships, we regressed adjusted quintiles categories
of PFOA on log transformed lymphocyte count, absolute neutrophil count, serum iron, serum
albumin and total bilirubin. Results were consistent with the continuous measure analysis in
tables 3.3 and 3.4. Specifically, there were statistically significant (p<0.001) monotonic and
linear associations in adjusted increasing quintiles categories of PFOA and log transformed
lymphocyte count, serum iron, serum albumin, and total bilirubin (p trend <0.001). On
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categorical quintile analysis, there was no significant trend between log transformed neutrophil
count and quintile categories of PFOA (p trend=0.183).
Figure 3.1
Percent Change in Inflammatory Markers Associated with Increasing PFOA

Adjusted Regression Coefficient (95% CI) for Change in Inflammatory
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Figure 3.2
Percent Change in Inflammatory Markers Associated with Increasing PFOA
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Discussion
In the present study, the statistical examination of PFC exposure and inflammation and
oxidative stress, reveal significant associations which bear important translational value for
population health protection. We found significant associations between biomarkers of PFCs and
markers of inflammation, immunity, oxidative stress and liver damage. PFCs along with a few
other chemicals have been linked with hepatocellular carcinoma which is known to have
inflammatory, dysplastic and trophic properties (Erkekoglu, Oral, Chao, & Kocer-Gumusel,
2017). In limited human studies of PFC exposure, significant associations have been noted
between PFOA and total bilirubin, gamma glutamyl transferase (GGT), alanine transaminase
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(ALT), and uric acid. PFOS was also significantly associated with total bilirubin and PFNA was
associated with ALT (Gleason et al., 2015), (Shankar, Xiao, & Ducatman, 2011).
These associations in humans are consistent with findings in mice where some markers of
oxidative stress (malondialdehyde, hydrogen peroxide generation) and markers of inflammation
(interleukin 6, cyclooxygenase-2 and C- reactive protein) were significantly induced by exposure
to PFOA for fourteen consecutive days (Yang et al., 2014). This study did not find any
significant positive associations between PFCs and c-reactive proteins (CRP) because ours was
for a longer period and not limited to fourteen days. Associations of the various metabolites with
CRP showed either a null or inverse association in our study which is not surprising due to
previous reports linking CRP as a marker of acute but not chronic or persistent inflammation;
hence the possible reason for the lack of statistical significance (Hajat et al., 2015), (Holzinger &
Föll, 2015).
This study observed an increase in serum bilirubin in association with all PFC
metabolites (PFHS, PFNA, PFOA, PFOS, and PFDE). These findings are consistent with a study
showing that PFOS and PFOA were associated with total bilirubin with evidence of an
increasing trend (Gleason et al., 2015). All PFCs biomarkers in our study showed statistically
significant associations with albumin indicating that PFCs exposure potentially caused an
oxidative process to trigger this increase.
A large body of clinical evidence have illustrated disease susceptibility and the response
to infection and inflammation worsen with elevated iron stores (Wessling-Resnick, 2010). While
we observed an increase in iron concentration with increase in PFHS, PFNA, PFOA, PFOS and
PFDE, PFC exposure did not show any association with ferritin possibly due to the small sample
size of individuals with ferritin data in the years studied (only one NHANES data cycle-2005).
82

Secondly, ferritin is primarily an active phase reactant (Northrop-Clewes, 2008) and the
pathology due to PFCs exposure as stated earlier, occurs due to prolonged and persistent
(chronic) exposure arising from its environmental persistence. Our study results also reveal a
positive linear relationship between PFCs exposure level and serum iron, albumin and bilirubin,
which may be indicative of anti-oxidant activity and liver damage.
In the present study, PFNA and PFDE had a negative association with ALP. In a similar
study carried out by Gleason et al, no significant associations were noted in the adjusted models
between PFOS, PFOA, PFNA and ALP. This is probably because like CRP, ALP is more suited
to the acute phase of inflammation. From our study, PFHS, PFNA, PFOA, PFOS and PFDE were
associated with a decrease in ANC. This means exposure to PFCs could potentially be associated
with inability of the human body to properly respond to an infection also. This was similar to
findings obtained from studies done involving mice (Agency for Toxic Substances and Disease
Registry (ATSDR), 2018).
From our study, PFHS, PFNA, PFOA, PFOS and PFDE were all associated with an
increase in lymphocyte count. PFOS was associated with increases in monocyte count with
borderline significance (not shown) indicating possible air pollutant (inhalational) contamination.
Studies looking at human white blood cell distribution pattern in response to PFC exposure are
lacking, however animal studies using mice showed on histology increased infiltration of
inflammatory cells in the liver cells of those exposed to PFOA (Yang et al., 2014). A positive
relationship of PFCs with lymphocytes and possibly monocyte counts provide compelling
support for further research because this could be an earlier indicator of liver impairment
especially when combined with the simultaneous association with increased serum iron and
serum bilirubin.
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PFCs are associated with markers of inflammation and oxidative stress. This means that
one of the potential mechanisms by which PFCs exposure causes morbidity is inflammation and
oxidative stress. Exposure to these chemicals can trigger inflammation in the organ systems in
the human body and these will lead to systemic diseases as has been seen with liver diseases and
evident derangements in biomarkers of normal liver function in this study and elsewhere in the
literature (Atsdr, 2018).
This study offers a unique contribution to the state of the science on the potential link
between PFC exposures and biomarkers of oxidative stress, inflammation, immunity possibly
liver damage in humans and it is among the first studies of its kind to use data from NHANES
using a fairly large sample size (n= 6,652). Our findings were robust to secondary stratified and
quintile analyses. This study was not without limitations- the cross-sectional study design limited
conclusions on causality due to temporal ambiguity. Secondly, a single measurement of PFC
biomarkers which was employed in sample collection may lead to exposure measurement error.
Future explorations to more thoroughly investigate these associations should involve more robust
study designs with longitudinal data and repeat blood sample collection for exposure assessment
while also utilizing advanced epidemiological analyses and toxicological studies.
Conclusion
PFCs biomarkers were associated with various markers indicative of oxidative stress,
liver damage, cellular immunity and chronic inflammation thus having implications in the
pathogenesis and prognosis of localized and multi-systemic disease processes, inflammation and
infections in humans. Continued research attention concerning PFC exposure and its relationship
to oxidative stress, inflammation, neutrophil responses to infection and organ (e.g. liver) disease
is warranted so that potential preventive strategies and insights limiting PFC exposure can be
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gained. In addition, policies aimed at further reducing exposure to these substances should be
considered while also further exploring and confirming the results of this investigation through
additional longitudinal studies.
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Abstract
Objectives
This study examined the association between perfluoroalkyl chemicals (PFCs) and a group of
estrogen related cancers and further explored if increased non-occupational exposure was
associated with increased odds of developing these cancers.
Methods
Using data from the National Health and Nutrition Examination Survey (NHANES), participants
were aged ≥ 20 years of age. Our outcome variable was presence or absence of cancer (yes/no),
our exposure variables were serum PFCs. Logistic regression models were used in investigating
the association between quartiles of PFCs exposure concentrations and presence or absence of
cancer while also adjusting for covariates. Discriminant analysis was used to assess the
correlation between individual PFCs compounds and individual cancer types.
Results
In each of the cancer types, PFCs were associated with increased odds of breast, prostate, uterine
and ovarian cancer. Increased quartile of exposures comparing the first and fourth quartiles were
also significantly associated (P<0.05) with increased odds of developing cancers. On
discriminant analysis, PFOA was more correlated with breast cancer (0.7), PFOS was more
correlated with prostatic cancer (0.760), PFHS was more correlated with uterine cancer (0.7) and
PFHS was more correlated with ovarian cancer (0.845).
Conclusion
Perfluoroalkyl chemicals are associated with estrogen-linked cancers and increased exposure in
non-occupational doses leads to increased odds of cancer.
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Introduction
Various compound derivatives of perfluoroalkyl substances (PFCs) have been used in the
United States (U.S.) due to remarkale surfactant properties (Agency for Toxic Substances and
Disease Registry (ATSDR), 2018). Though some compound productions have been banned,
those banned are persistent in the environment and human biological systems while others are
still being produced as break-down products of other chemical derivatives. Humans get exposed
to these chemicals when they use products containing them such as in food packaging materials,
fire-fighting foams as especially deployed by the military, cook-ware, shaving creams and
shaving sticks (Agency for Toxic Substances and Disease Registry (ATSDR), 2018).
Perfluorinated chemicals (PFCs) are known endocrine disruptors (Wan et al., 2013).
Endocrine disruptors have been linked with breast cancer (Morgan, Deoraj, Felty, & Roy, 2017),
endometrial cancer (Mallozzi, Leone, Manurita, Bellati, & Caserta, 2017), lung cancer (Hsu,
Chu, & Kao, 2017), and other female cancers (Rachoń, 2015), as well as metabolic conditions
like obesity (Darbre, 2017). Specifically, endocrine disrupting chemicals which are known for
having the potential to interfere with endocrine homeostatsis have been associated with estrogen
disruption and thus subsequent development of malignancies (Gibson & Saunders, 2014).
Known estrogenic cancers include breast cancer, prostatic cancer, endomerial/uterine cancer and
ovarian cancer. Breast and prostate cancers are the commonest gender specific cancers in women
and men respectively in the United States (U.S.) with a significant toll on morbidity, mortality
and health care resources. Together, about 600,000 new cases of these cancers were diagnosed in
the U.S. in 2019 (“Common Cancer Types - National Cancer Institute,” sourced from
https://www.cancer.gov/types/common-cancers on 12.01.2019.).
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Estrogen is a sex hormone present in the form of 17 β estradiol, estriol and estrone in the
human body (Liang & Shang, 2013). Its signalling and signalling perturbations can give rise to
both genomic and non-genomic tumor cell promotion. By binding to intracellular receptors,
estrogen receptor alpha and estrogen receptor beta, estrogen is able to orchestrate its biological
effects by first acting as a ligand activator of gene transcription or by ligand stimulation of signal
tranduction within cells (Liang & Shang, 2013). In addition, these chemicals are thought to have
immune regulatory roles as well (Rothenberger, Somasundaram, & Stabile, 2018) and as such act
as pro-tumor agents by cutting off immune signalling which are necessary to curtail the spread of
neoplastic agents.
This study examined the potential relationship between perfluoroalyl chemicals and each
estrogenic cancer across categories of PFCs exposure and determined the concentration, if any,
of PFCs that would be associated with increased odds of estrogenic carcinogenesis when
compared with the lowest exposure category. Also, we investigated posssible concentration cutoffs associated with the development of such cancers.
To the best of our knowledge, there are paucities of studies that have looked at
perfluoroalkyl compound exposure and these four estrogenic cancers as a pathologic entity. Also,
limited to no studies, to the best of our knowledge, has looked at this association across
categories (quartiles) of PFCs exposure. We hypothesize that PFCs exposure is associated with at
least one of the estrogenic cancers and that this varies across categories of PFCs exposure with
higher exposure levels having higher odds of cancer prevalence.
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Methods
Study Population
Sample data were obtained from the National Health and Nutrition Examnation Survey
(NHANES) from year 2005-2012. NHANES is a national representative data survey of noninstitutionalized civilian US residents carried out in yearly cycles with participants interviewed
in their homes and physical and laboratory samples and measurements taken in mobile
examination centers (“NHANES - About the National Health and Nutrition Examination
Survey,Sourced from https://www.cdc.gov/nchs/nhanes/about_nhanes.htm on 10.28.2019). We
included data from men and women greater than or equal to 20 years of age who had
perfluorinated chemical substances measured on their serum samples and had been interviewed
regarding their past and current medical conditions. After excluding those who did not fufill our
inclusion criteria, our sample size was n=6652. We excluded participants less than 20 years of
age.
Questionnaires were administered both at home and in mobile examination centers. Detailed
description of the questionnaire used are described elsewhere in the Centers for Disease Control
and Prevention website.
Outcome Variables
The outcome variables were ovarian cancer, prostate cancer, breast cancer, and uterine
cancer. Breast cancer (yes/no) was determined by response to the question “have you ever been
told you have breast cancer; uterine cancer (yes/no) was determined by response to the question
“have you ever been told you had uterine (endometrial) cancer”; ovarian cancer (yes/no) was
determined by response to the question “have you ever been told you had ovarian cancer”, and
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prostate cancer (yes/no) was determined by response to the question “have you ever been told
you had prostatic cancer”.
Exposure Variables
Five perfluoroalkyl chemical compounds including PFOA,PFOS, PFNA, PFHS, and
PFDE were measured in blood samples collected at the Mobile examination Centers and were
processed and shipped to the Centers for Disease Control and Prevention laboratories. Samples
were analyzed for PFCs using solid phase extraction chromatography coupled to High
Performance Liquid Chromatography-Turbo Ion Spray ionization-tandem mass spectrometry.
Details ahave been described elsewhere (“NHANES 2007-2008 Laboratory Data Overview,
sourced from
https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2007 on
10.28.2019”.). Our analysis was focused on PFCs detected in greater than 95% of the study
participants based on the limit of detection. PFCs below the limit of detection (LOD) were
assigned a value of the lod for the given year divided by the square root of 2.
Covariates
Covariates- including age, poverty-income-ratio, sex, ethnicity, education level body
mass index (BMI) and cotinine levels were collected using Computer Assisted Personal
Interviewing. Sex was modelled as a dichotomous variable, race/ethnicicty and education were
modelled as categorical variables, all other variables including PIR, cotinine level, BMI and age
were modelled as continous variables. Specifically, race consisted of Mexican American, Other
Hispanic, Non-Hispanic White, Non-Hispanic Black, Other-Race. Education comprised less than
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9th grade, 9th-11th grade, high school graduate or equivalent, some college or associate degree and
college graduate or greater.
Statistical Analysis
Descriptive analysis was used for demonstrating participants’ characteristics and
demographics. Association between PFCs exposure and estrogenic cancers individually were
assessed using logistic regression models and using the Fisher’s scoring optimization technique.
Number of observations used for analysis was 6091. Participants with missing response or
explanatory variables (n=32,309) were excluded from the analysis. Our model with covariates fit
better than the intercept only model with -2Log L being 555.326 for the former and 860.777 for
the latter. Our likelihood ratio testing the null hypothesis that there was no sinificant difference
was <0.0001.
We modelled the probability that our response variables- breast cancer, prostate cancer,
uterine cancer and ovarian cancer were equal to one (presence of cancer). Categorizing PFCs
into quartiles of exposure and modelling the odds of developing each cancer type individually,
we took the reference category for the exposure variable as quartile 1 and absence of cancer as
the reference category for the outcome variable. In other words, we modelled the odds of
developing cancer for particiants in quartiles 2, 3 and 4 versus quartile 1. Quartiles of PFCS
exposure were then analyzed in logistic regression models while adjusting for covariates to
assess the logit relationship with the outcome variables- (each estrogenic cancer individually).
We used MEC weights corresponding to the smallest subsample (PFCs group) and
corresponding to 8 survey years by dividing the two year cycle weights WTMEC2YR by 4 as
described in detail elsewhere (“NHANES Tutorials - Module 3 - Weighting, sourced from
https://wwwn.cdc.gov/nchs/nhanes/tutorials/module3.aspx on 10.29.2019”).
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To assess which PFCs compound was associated with a particular cancer subtype, we
performed a discriminant function analysis to identify which particular PFCs compound was
more correlated with the presence or absence of a particular cancer using canonical correlation
coefficients. All data analyses were performed using SAS 9.4 (Cary, NC) and R.
Results
Table 4.1 shows descriptive statistics for the study population. The mean age for the
participants was 49.4 (±18.07) years. A slight majority were female (51.2%), Non Hispanic
White (46.5%) and had an average family income to poverty ratio of 2.53(± 1.62). More of the
participants had attained some college or AA degree (28.4%). A majority of the participants had
little or no second-hand tobacco smoke exposure (74.6%). Roughly 5% of the participants had
been diagnosed with breast or prostate cancer at a point in their lives while 83 and 47
participants had been diagnosed with uterine and ovarian cancers respectively.
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Table 4.1
Demographic Characteristics of Study Participants NHANES 2005-2012
Participants (n=6652)
Variable

n (%)

Age (years)
Gender
males
females
Family Poverty-Income-Ratio

Mean (± sd)

49.40(±18.07)
3246(48.8)
3406(51.2)
2.53(±1.62)

Education
Less than 9th grade
9th -11th grade
High School grad/ GED or
equivalent
Some college or AA degree
College Grad or Above
Refused
Don’t Know

817(12.28)
1,033(15.53)
1,455(21.87)
1,889(28.40)
1,447(21.75)
3(0.05)
8(0.12)

Race/ethnicity
Mexican American
Other Hispanic
Non-Hispanic White
Non-Hispanic Black
Other/multi-racial

1,088(16.4)
597(9.0)
3,094(46.5)
1,358(20.4)
515(7.7)

Serum cotinine, nmol/l (ng/ml)
<5.68 (1) (no or little STS
exposure)
5.68-56.8 (1-10) (high STS
exposure)
>56.8 (10) smoker)

4964(74.6)
283(4.3)
1404(21.10)

Breast cancer
Yes
No
Prostate cancer
Yes
No
Uterine cancer
Yes
No
Ovarian cancer
Yes
No

325(4.9)
6327(95.1)
316(4.8)
6336(95.2)
83(1.2)
6569(98.8)
47(0.7)
6605(99.3)

Abbreviations :AA, associate degree; GED, general education development;, interquartile range;
STS, second hand tobacco smoke.

104

Table 4.2 shows the distribution of serum PFC concentrations. The median serum
concentration for PFDE, PFHS, PFNA, PFOA, PFOS were 0.30, 1.60, 1.10, 3.20, 11.40
respectively. Maximum values ranged from 25.0 to 281.0 for the respective PFCs.
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Table 4.2
Serum Concentrations of PFCs (ng/ml) NHANES 2005-2012 (n=6,652)

Analyte

LOD
BY
CYCLE
0506

07-08

PFDE

0.20

PFHS

N (%) >LOD

0910

1112

0.20

0.10

0.10

0.10

0.10

0.10

PFNA

0.10

0.08

PFOA

0.10

PFOS

0.20

Percentiles

mean 10th

25th

50th

75th

90th

95th

Max

6344(95.4)

0.30

0.13

0.16

0.30

0.42

0.74

1.10

25.0

0.10

6538(98.3)

1.60

0.44

0.90

1.60

2.80

4.61

6.60

82.0

0.08

0.08

6599(99.2)

1.10

0.50

0.74

1.10

1.65

2.60

3.39

81.0

0.10

0.10

0.10

6628(99.6)

3.20

1.28

2.00

3.20

4.90

7.10

8.90

104.0

0.20

0.20

0.20

6635(99.7)

11.40

3.60

6.45

11.40

19.68

32.30 42.70 281.0

Abbreviations: LOD, limit of detection.

Table 4.3 shows the odds ratio of the respective cancers for participants who are in
quartile 2, quartile 3 and quartile 4 category of exposure for the PFCs compounds versus those in
quartile 1 category of exposure. For ovarian cancer, the odds increased with increasing quartiles
of exposure for each PFCs compound. For prostate cancer, increased odds ranged from 27% to
77% and in some cases over a 100% (odds ratio of 2.62) compared to participants in the first
quartile, for PFOA exposure. For PFOS, the odds increase ranged from 1% to 12%, it appeared
to increase in quartile 3 and then decrease in quartile 4, the same is true for PFNA exposure odds
ratio. Increasing PFHS exposure had reduced odds of prostate cancer with similar findings for
PFDE exposure except when comparing quartile 3 to quartile 1 which had 16% increase in odds.
PFCs compounds all showed increased odds of breast cancer when one or more quartiles of
exposure were compared to the first or least exposure quartile. The same trend was not observed
with PFOS and uterine cancer as the odds ratio were either below one or not significant at an
alpha level of 0.05. For the ovarian cancer type, when comparing quartile 4 to quartile 1, all
PFCs were associated with increased odds of ovarian cancer ranging from over 70% to a
doubling of the odds. PFOA, PFNA, PFHS and PFDE all had at least one category with
increased odds of developing prostate cancer when compared to the quartile one.

Table 4.3
Associations between PFCs Quartiles of Exposure and Estrogenic Cancers

PFOA

Reference Quartile
1

Ovarian Cancer
OR(CI)

Prostate Cancer
OR(CI)

Quartile 2 versus 1

0.07
(0.07, 0.072)
0.69
(0.68,0.70)
1.77
(1.75,1.79)
0.08
(0.08,0.084)

2.62
(2.59, 2.64)
1.77
(1.76, 1.79)
1.27
(1.26,1.28)
0.68
(0.67,0.69)

Breast
Cancer
OR(CI)
2.40
(2.38,2.42)
1.39
(1.38,1.40)
2.30
(2.28,2.31)
0.89
(0.86,0.87)

1.64
(1.62,1.66)
2.25
(2.22,2.28)
0.00
(0.00,0.001)
0.79
(0.78,0.80)
1.80
(1.78,1.82)
0.43
(0.424,0.438)
0.69
(0.68,0.70)
1.86
(1.84,1.88)
0.00
(0.00,.002)
1.13
(1.11,1.14)
2.11
(2.09,2.14)

1.12
(1.104,1.13)
1.01
(1.00,1,02)
0.28
(0.28, 0.29)
1.75
(1.73,1.76)
0.59
(0.58,0.59)
0.96
(0.95,0.97)
0.51
(0.50,0.51)
0.62
(0.62,0.63)
0.33
(0.33,0.34)
1.16
(1.16, 1.17)
0.50
(0.49,0.50)

1.06
(1.05,1.06)
1.47
(1.46,1.48)
0.51
(0.51,0.52)
1.05
(1.05,1.06)
1.04
(1.03,1.05)
9.36
(9.23,9.50)
7.05
(6.94,7.15)
7.07
(6.97,7.17)
1.39
(1.38, 1.39)
1.44
(1.43,1.45)
1.38
(1.37,1.39)

Quartile 3 versus 1
Quartile 4 versus 1
PFOS

Quartile 2 versus 1

Quartile 3 versus 1
Quartile 4 versus 1
PFNA

Quartile 2 versus 1
Quartile 3 versus 1
Quartile 4 versus1

PFHS

Quartile 2 versus 1
Quartile 3 versus1
Quartile 4 versus 1

PFDE

Quartile 2 versus1
Quartile 3 versus 1
Quartile 4 versus 1

Quartile 1 is least exposure quartile
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Uterine Cancer
OR(CI)

1.35
(1.34, 1.37)
0.54
(0.54,0.55)
Not sig
1.0
(0.99,1.00)
0.08
(0.08,0.08)
0.45
(0.45, 0.46)
1.21
(1.20,1.23)

0.62
(0.62,0.63)
1.76
(1.74,1.78)
0.44
(0.43,0.44)
0.16
(0.16, 0.16)
1.65
(1.63,1.67)
1.12
(1.11,1.14)
1.40
(1.38,1.42)

Table 4.4 shows standardized canonical discriminant function within-group correlations
of PFCs compounds. The correlations are ordered by absolute size. Strong correlations (>0.7)
were seen between PFOA and breast cancer, PFOS and prostatic cancer, PFHS and uterine
cancer and between PFHS and ovarian cancer.

Table 4.4
Correlations of PFCs using Standardized Canonical Discriminant Functions

Highly correlated
with cancer
category

Less correlated
with cancer
category

Breast Cancer
(correlation)

Prostate Cancer
(correlation)

Uterine Cancer
(correlation)

Ovarian Cancer
(correlation)

PFOA (0.698)

PFOS (0.760)

PFHS (0.685)

PFHS (0.845)

PFOS (0.588)

PFHS (0.152)

PFOA (-0.409)

PFOS (0.556)

PFNA (0.245)

PFNA (0.137)

PFNA (0.096)

PFDE (0.468)

PFHS (-0.044)

PFDE (0.085)

PFOS (0.060)

PFNA (0.243)

PFDE (-0.017)

PFOA (0.010)

PFDE (0.013)

PFOA (0.058)

Discussion
Our results showed increasing odds of cancer with increasing PFCs compound exposure
for all types of estrogenic cancers. Further, we were able to identify PFCs exposures that were
more correlated with a particular type of estrogenic cancer- PFOA for breast cancer, PFOS for
prostatic cancer, PFHS for uterine cancer and PFHS for ovarian cancer.
A few studies have tried to draw a link between perfluorinated chemical exposure and
breast cancer. In a nested cohort study carried out in Denmark, PFOSA and PFHxS were both
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associated with breast cancer risk (Bonefeld-Jorgensen et al., 2011). Studies have tried to link the
development of breast cancer to windows of susceptibility during the exposure period (Terry et
al., 2019) as well as endocrine disruptors acting through cytosolic and nuclear receptors,
interacting with complex molecules known as ligands in the cytosol and activating enzymatic
pathways like the Src/Ras/Erk. Other postulated mechanisms include the modulating effect of
nitric oxide, changes in feedback modulation, deoxyribonucleic acid (DNA) and histone
modulations as well as interference with spindle formation (De Coster & Van Larebeke, 2012).
These mechanisms have been associated with endocrine disruptors as a class of compounds and
not just perfluorinated compounds. As we found in our study, Bonefeld-Jorgensen et al also
noted stronger associations of breast cancer cases with higher quintiles of exposure.
Ovarian cancers have been linked to other environmetal exposures such as the pulp and
paper industry but links of these cancers to environmental factors have been sparse and far
between at best (Hanchette, Zhang, & Schwartz, 2018). While others may have contradicted the
existence of an association (Donat-Vargas et al., 2016), a few studies have implicated geneenvironment interactions like the use of oral contraceptive pills which may provide protective
benefits (Kim et al., 2019). In our study we found increasing odds of ovarian cancer with
increased exposure to PFCs and among the PFCs, PFHS showed strong abilities to discriminate
between the presence or absence of ovarian cancer.
A number of environmental exposure have been linked with prostate cancer risk such as
cadmium, pesticides, and bisphenol A (Rapisarda et al., 2018)(Silva, Mattos, Luz, Carmo, &
Aydos, 2016)(Tse et al., 2017) but none to the best of our knowledge has directly linked PFCs
with prostatic cancers. Quintile category associations with prostatic cancer was noted when
comparing the cummulative BPA exposure and prostate cancer with increased odds ratio seen in
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the high versus the low cummulative BPA exposure (Tse et al., 2017). This was similar to
findings in our own study, albeit ours involved more than one quartile of exposure versus the
least quartile of exposure, for example PFOA had increased odds in all of quartiles 2,3,4 in
comparison to quartile one.
Environmental exposures and endocrine disrupting chemicals such as bisphenol A have
been linked with uterine neoplasms like uterine fibroids, uterine leiomyoma, (Katz, Yang,
Treviño, Walker, & Al-Hendy, 2016). Other authors in China have also linked the consumption
of soybean milk, exposure to products made of plastic, use of cosmetics, food additives and
sweetners to the development of uterine leiomyomas (Shen, Xu, Xu, Ren, & Cai, 2013). None
have linked PFCs exposure with these neoplasms or uterine cancers specifically. In this study,
there were increased odds of uterine cancer in higher exposure categories of PFCs when
compared to the least exposure category especially for PFDE.
With quartiles 2 for PFOA, PFDE, PFNA and PFHS been associated with increased odds
of ovarian , uterine, prostate and breast cancers, it may be safe to say that estrogenic cancer-free
exposure levels are well below quartile two for these four compounds and would be considered
safe levels. From table 2, quartile 2 corresponds to 3.20ng/ml for PFOA, 0.3ng/ml for PFDE,
1.10ng/ml for PFNA and 1.60ng/ml for PFHS, therefore safe limits should at least be well below
these levels and even quartile 1 possibly. For PFOS, this corresponds to quartile 3 with an
associated dose of 19.68ng/ml, therefore estrogenic cancer-safe levels should be well below this
value.
This study had some limitations. First, this is a cross-sectional study and due to it’s
temporal ambiguity, causality cannot be established. Second, information bias cannot be ruled
out as cancer diagnoisis was based on self report. Third, random errors from single
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measurements of PFCs in blood samples could lead to non-differential missclassifications and
lastly, temporal trends in PFCs exposure could lead to differential misclassifications towards the
null.
To the best of our knowledge there are lack of studies looking at estrogenic cancers as a
group or entity influenced by the non-occupational exposure to perfluorinated chemicals. This
study presents a state-of-the-science research and analysis in examining highly detectable PFCs
compounds and their associations with these cancers with the aim of trying to decipher the
strength of the associations, a possible threshold level of exposure and promulgation of policies
to protect the general public from the menace of these often overlooked chemicals. Our findings
imply that exposures to these chemicals from their various sources and through their various
routes could lead to increased incidence and prevalence of breast cancer, prostate cancer, ovarian
cancer and uterine cancer. Increased cancer odds virtually affects all levels of exposure generally
but the higher the exposure the greater the odds of developing cancer.
Conclusion
PFCs were associated with estrogenic cancers and increasing exposure levels for the most
part leads to increase in the odds of developing one or more of the estrogenic cancers. Safe
thresholds from the calculations below the limits of detection are to be set for these compounds
to prevent the incidence of estrogenic cancers and other morbidities that may arise there-of.
Policy aimed at setting minimum or threshold exposure levels and doses should be promulgated
by government agencies so that the vast array of morbidities that are associated with exposures
to these chemicals may be reduced.
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Chapter 5. Discussion and Conclusion
Findings from our cross-sectional study indicates that perfluorinated chemical
compounds, specifically perfluorononanoic acid are associated with central obesity in females.
Perfluorodecanoic acid and perfluorooctanoic acid are suggestively significantly associated with
elevated cholesterol and elevated blood glucose levels. Phthalates, specifically DEHP
metabolite- mono2-ethyl-5-hydroxyhexyl phthalate are associated with central obesity in
females, hypertriglyceridemia and hypercholesterolemia. PFCs exposures and phthalate
exposures did not interact additively. This means that PFCs and phthalates as individualized
compounds acting alone are responsible for central obesity in females and diabetes and
hypercholesterolemia in both males and females when the population is simultaneously exposed.
All PFCs were associated with markers of chronic inflammation- lymphocytes. We did
not see associations between PFCs and other acute markers of inflammation such as C-reactive
protein and serum ferritin, and we observed an inverse association with the acute phase markerabsolute neutrophil counts. Specifically, we noticed strong associations between PFCs
compounds and systemic markers of liver disease such as serum iron and with markers of
oxidative damage such as serum total bilirubin and serum albumin. Serum total bilirubin is also a
marker of liver disease. These findings were supported by both continuous and categorical data
analysis. On categorical analysis, we found significant trends between quintiles of
perfluorooctanoic acid exposure and lymphocyte count, serum albumin, serum iron and serum
total bilirubin levels. We did not find any significant trend in the association between
perfluorooctanoic acid and absolute neutrophil count. This implies that the mechanisms by which
PFCs cause disease include inflammation and oxidative stress and that the liver is a primary
target organ for the systemic effects of PFCs.
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From this study, we observed that the lowest exposure quartile in non-occupationally
exposed individuals are at risk of carcinogenesis. Exposure to this dangerous substance therefore
needs curtailment by government agencies due to the plethora of diseases they cause. Currently,
for most of the PFCs, there are no limits of exposure set forth by government agencies for within
or outside the workplace. Setting minimum exposure limits for these chemicals through enforced
regulations and recommendations will help in reducing exposures; measures like this have been
used with other toxic exposures like benzene. These regulations can be expressed as ‘Not to
exceed levels’ in air, soil, water or food. The EPA currently has advisories for PFOA and PFOS
of 0.4 and 0.2 microgram per liter respectively; going by our findings, this should be made much
lower to 0.1 microgram per liter for PFOS.
This Study’s findings indicate that PFCs are associated with estrogenic cancers. Increased
exposure to these compounds are strongly associated with breast, prostate, uterine and ovarian
cancers. We also noted that though increasing exposure concentrations are associated with
increased odds, maximum exposure is not needed for the odds of these cancers to increase; slight
or minimal exposure increases are associated with more than doubling of the odds of cancer risk
in some instances.
PFCs exposure is associated with obesity and estrogenic cancers with inflammation and
oxidative stress acting as potential mechanisms for these two health conditions. Impairment in
the redox pathway has been known to give rise to oxidative stress a condition where reactive
oxygen species (ROS) and reactive nitrogen species (RNS) are being produced faster than they
are being removed from the body. When there is an impairment in this pathway, it gives room
for reactive oxygen species to thrive leading to oxidation of cells in the body; oxidation of cells
gives rise to cellular damage (Goljan, 2014) and this in turn leads to pathologies like cancer.
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Carcinogenic cells on their own create more reactive oxygen species (Gurer-Orhan, Ince,
Konyar, Saso, & Suzen, 2017) leading to a vicious cycle. Oxidative stress has also been shown to
play a fundamental role in the development of ovarian cancer as well (Saed, Diamond, &
Fletcher, 2017) by creating a communication medium by which distinct cells in the body
communicate with and influence each other. This points to the diversification and inter-linking of
processes by which PFCs exposure induces disease formation through oxidative damage and
once started, could lead to a vicious cycle of more cellular damage and more diseases.
Chronic inflammation coupled with infection and hypoxia (oxygen lack) are the main
drivers of oxidative stress (Saed et al., 2017). With PFCs exposure linked to chronic
inflammation from our study and oxidative stress, and with the literature suggesting that
inflammation triggers obesity and cancer and cancer and obesity triggering inflammation (Cox,
West, & Cripps, 2015), PFCs exposure can be described as a complex trifecta of attributes
consisting of inflammation, oxidative stress and disease manifestations existing side by side and
possibly potentiating each other.
More large-scale prospective studies are needed to corroborate the findings of this study.
Importantly, more laboratory studies are needed to establish threshold doses for cancer
occurrence. We also need novel markers that may be identified as specific to PFCs exposure and
organ disease pathologies as well as possible target genes and exact pathways that may be
affected in systemic disease. Furthermore, studies may want to explore why the chemical
compounds identified for causing central obesity are specific to the female gender and if there
are any gender specific factors that promote this disease pathologies.
Investigations should be commenced into how other socio-demographic characteristics
such as lifestyle and diet and other exposure-related factors influence blood levels of PFCs. Also
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worthy of investigating is the presence or absence of unique mechanisms of action in individuals
that may be causing disease. A lot is still not known on how PFCs are transported from one
region to another, their fate in different environmental mediums, and effective ways to treat
PFCs in landfills, waste-water, soil and ground water.
With all the unknowns about PFCs fate, transport and extent of disease pathologies, we
can all do our parts from a public health stance with the little we know. From the literature,
economic development and technological advancements have been the main drivers of PFCs
pollution. When these chemicals were produced, there was persistent pressure to produce more
of them due to their wide-spread utility. Production of these chemicals leads to waste products
which are by-products of PFCs or PFCs themselves which are both toxic to the individual, the
community and the environment. Their ability to be transported by long range transport leads to
both local and widespread pollution. On getting into the environment, external exposure to these
compounds leads to an absorbed dose. A fraction of the absorbed dose gets into the target organ
or tissue to cause morbidity and mortality.
Environmental exposures like this needs and leads scientists to do an environmental and
epidemiological assessment. When this is done correctly the action is taken to abate the exposure
from its source. This is done through economic and social policies that promote the use of clean
technology or the use of alternative products. Where alternative products cannot be used,
emission control is resulted to through use of advanced air filter system, superior HVAC systems
in the workplace and restriction on exposure limits. These controls should be persistently
evaluated with process/impact/outcome evaluations. When done correctly, there are
improvements (reductions) in the PFCs concentrations and levels of pollution in the
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environment. For the fraction of the exposure that cannot be controlled for, education and
awareness are created at the workplace, community and individual level.
In some instances, diseases cannot be avoided hence the pathologic mechanisms and
disease processes explained above result. To prevent this, the Environmental Protection Agency
(EPA), puts forward advisories which should be constantly reviewed or updated, in addition,
regulations in the form of “Not to exceed levels” in air, soil, water and food should be expressed,
recommended and possibly enacted as laws by government agencies. Minimum allowable
threshold levels can also be set for occupational exposures (especially PFCs manufacturing
facilities) by the Occupational Safety and Health Administration (OSHA) and the National
Institute for Occupational Safety and Health, (NIOSH); drinking water levels in communities
with and without PFCs manufacturing facilities set by the EPA. Food is also regulated especially
fish by the Food and Drug Administration, FDA and ambient 24- hour exposures for
background/general population studies by the EPA.
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